Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
11 "Genomics"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Sarcoma
Case Series of Soft Tissue Sarcoma Patients with Brain Metastasis with Implications from Genomic and Transcriptomic Analysis
Changhee Park, Rokhyun Kim, Jaeyong Choi, Miso Kim, Tae Min Kim, Ilkyu Han, Jong-Il Kim, Han-Soo Kim
Cancer Res Treat. 2024;56(2):665-674.   Published online September 27, 2023
DOI: https://doi.org/10.4143/crt.2023.864
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Brain metastasis rarely occurs in soft tissue sarcoma (STS). Here, we present five cases of STS with brain metastases with genetic profiles.
Materials and Methods
We included five patients from Seoul National University Hospital who were diagnosed with STS with metastasis to the brain. Tissue from the brain metastasis along with that from the primary site or other metastases were used for DNA and RNA sequencing to identify genetic profiles. Gene expression profiles were compared with sarcoma samples from The Cancer Genome Atlas.
Results
The overall survival after diagnosis of brain metastasis ranged from 2.2 to 34.3 months. Comparison of mutational profiles between brain metastases and matched primary or other metastatic samples showed similar profiles. In two patients, copy number variation profiles between brain metastasis and other tumors showed several differences including MYCL, JUN, MYC, and DDR2 amplification. Gene ontology analysis showed that the group of genes significantly highly expressed in the brain metastasis samples was enriched in the G-protein coupled receptor activity, structural constituent of chromatin, protein heterodimerization activity, and binding of DNA, RNA, and protein. Gene set enrichment analysis showed enrichment in the pathway of neuroactive ligand-receptor interaction and systemic lupus erythematosus.
Conclusion
The five patients had variable ranges of clinical courses and outcomes. Genomic and transcriptomic analysis of STS with brain metastasis implicates possible involvement of complex expression modification and epigenetic changes rather than the addition of single driver gene alteration.
  • 3,923 View
  • 160 Download
Close layer
Lung and Thoracic cancer
Clinical Impact of Genomic and Pathway Alterations in Stage I EGFR-Mutant Lung Adenocarcinoma
Jae Seok Lee, Eun Kyung Kim, Kyung A Kim, Hyo Sup Shim
Cancer Res Treat. 2024;56(1):104-114.   Published online July 24, 2023
DOI: https://doi.org/10.4143/crt.2023.728
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
We investigated the clinical impact of genomic and pathway alterations in stage I epidermal growth factor receptor (EGFR)–mutant lung adenocarcinomas, which have a high recurrence rate despite complete surgical resection.
Materials and Methods
Out of the initial cohort of 257 patients with completely resected stage I EGFR-mutant lung adenocarcinoma, tumor samples from 105 patients were subjected to analysis using large-panel next-generation sequencing. We analyzed 11 canonical oncogenic pathways and determined the number of pathway alterations (NPA). Survival analyses were performed based on co-occurring alterations and NPA in three patient groups: all patients, patients with International Association for the Study of Lung Cancer (IASLC) pathology grade 2, and patients with recurrent tumors treated with EGFR–tyrosine kinase inhibitor (TKI).
Results
In the univariate analysis, pathological stage, IASLC grade, TP53 mutation, NPA, phosphoinositide 3-kinase pathway, p53 pathway, and cell cycle pathway exhibited significant associations with worse recurrence-free survival (RFS). Moreover, RPS6KB1 or EGFR amplifications were linked to a poorer RFS. Multivariate analysis revealed that pathologic stage, IASLC grade, and cell cycle pathway alteration were independent poor prognostic factors for RFS (p=0.002, p < 0.001, and p=0.006, respectively). In the grade 2 subgroup, higher NPA was independently associated with worse RFS (p=0.003). Additionally, in patients with recurrence treated with EGFR-TKIs, co-occurring TP53 mutations were linked to shorter progression-free survival (p=0.025).
Conclusion
Genomic and pathway alterations, particularly cell cycle alterations, high NPA, and TP53 mutations, were associated with worse clinical outcomes in stage I EGFR-mutant lung adenocarcinoma. These findings may have implications for risk stratification and the development of new therapeutic strategies in early-stage EGFR-mutant lung cancer patients.
  • 3,069 View
  • 200 Download
Close layer
General
Clinicopathological Characteristics of NRG1 Fusion–Positive Solid Tumors in Korean Patients
Yoon Jin Cha, Chung Lee, Bio Joo, Kyung A Kim, Choong-kun Lee, Hyo Sup Shim
Cancer Res Treat. 2023;55(4):1087-1095.   Published online June 15, 2023
DOI: https://doi.org/10.4143/crt.2023.682
AbstractAbstract PDFPubReaderePub
Purpose
Neuregulin 1 (NRG1) gene fusion is a potentially actionable oncogenic driver. The oncoprotein binds to ERBB3-ERBB2 heterodimers and activates downstream signaling, supporting a therapeutic approach for inhibiting ERBB3/ERBB2. However, the frequency and clinicopathological features of solid tumors harboring NRG1 fusions in Korean patients remain largely unknown.
Materials and Methods
We reviewed archival data from next-generation sequencing panel tests conducted at a single institution, specifically selecting patients with in-frame fusions that preserved the functional domain. The clinicopathological characteristics of patients harboring NRG1 fusions were retrospectively reviewed.
Results
Out of 8,148 patients, NRG1 fusions were identified in 22 patients (0.27%). The average age of the patients was 59 years (range, 32 to 78 years), and the male-to-female ratio was 1:1.2. The lung was the most frequently observed primary site (n=13), followed by the pancreaticobiliary tract (n=3), gastrointestinal tract (n=2, stomach and rectum each), ovary (n=2), breast (n=1), and soft tissue (n=1). Histologically, all tumors demonstrated adenocarcinoma histology, with the exception of one case of sarcoma. CD74 (n=8) and SLC3A2 (n=4) were the most frequently identified fusion partners. Dominant features included the presence of fewer than three co-occurring genetic alterations, a low tumor mutation burden, and low programmed death-ligand 1 expression. Various clinical responses were observed in patients with NRG1 fusions.
Conclusion
Despite the rarity of NRG1 fusions in Korean patients with solid tumors, identification through next-generation sequencing enables the possibility of new targeted therapies.

Citations

Citations to this article as recorded by  
  • Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors
    Chunwei Xu, Qian Wang, Dong Wang, Wenxian Wang, Wenfeng Fang, Ziming Li, Aijun Liu, Jinpu Yu, Wenzhao Zhong, Zhijie Wang, Yongchang Zhang, Jingjing Liu, Shirong Zhang, Xiuyu Cai, Anwen Liu, Wen Li, Ping Zhan, Hongbing Liu, Tangfeng Lv, Liyun Miao, Lingfen
    Global Medical Genetics.2024; 11(01): 086.     CrossRef
  • Analysis on the pathogenesis and treatment progress of NRG1 fusion-positive non-small cell lung cancer
    Hongyan Li, Lina Xu, Hongshun Cao, Tianyi Wang, Siwen Yang, Yixin Tong, Linlin Wang, Qiang Liu
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Analysis of CD74 Occurrence in Oncogenic Fusion Proteins
    Jasmine Vargas, Georgios Pantouris
    International Journal of Molecular Sciences.2023; 24(21): 15981.     CrossRef
  • 3,647 View
  • 237 Download
  • 3 Web of Science
  • 3 Crossref
Close layer
Gastrointestinal cancer
Clinical Application of Targeted Deep Sequencing in Metastatic Colorectal Cancer Patients: Actionable Genomic Alteration in K-MASTER Project
Youngwoo Lee, Soohyeon Lee, Jae Sook Sung, Hee-Joon Chung, Ah-reum Lim, Ju Won Kim, Yoon Ji Choi, Kyong Hwa Park, Yeul Hong Kim
Cancer Res Treat. 2021;53(1):123-130.   Published online August 18, 2020
DOI: https://doi.org/10.4143/crt.2020.559
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Next-generation sequencing (NGS) can facilitate precision medicine approaches in metastatic colorectal cancer (mCRC) patients. We investigated the molecular profiling of Korean mCRC patients under the K-MASTER project which was initiated in June 2017 as a nationwide precision medicine oncology clinical trial platform which used NGS assay to screen actionable mutations.
Materials and Methods
As of 22 January 2020, total of 994 mCRC patients were registered in K-MASTER project. Targeted sequencing was performed using three platforms which were composed of the K-MASTER cancer panel v1.1 and the SNUH FIRST Cancer Panel v3.01. If tumor tissue was not available, cell-free DNA was extracted and the targeted sequencing was performed by Axen Cancer Panel as a liquid biopsy.
Results
In 994 mCRC patients, we found 1,564 clinically meaningful pathogenic variants which mutated in 71 genes. Anti-EGFR therapy candidates were 467 patients (47.0%) and BRAF V600E mutation (n=47, 4.7%), deficient mismatch repair/microsatellite instability–high (n=15, 1.5%), HER2 amplifications (n=10, 1.0%) could be incorporated with recently approved drugs. The patients with high tumor mutation burden (n=101, 12.7%) and DNA damaging response and repair defect pathway alteration (n=42, 4.2%) could be enrolled clinical trials with immune checkpoint inhibitors. There were more colorectal cancer molecular alterations such as PIK3CA, KRAS G12C, atypical BRAF, and HER2 mutations and even rarer but actionable genes that approved or ongoing clinical trials in other solid tumors.
Conclusion
K-MASTER project provides an intriguing background to investigate new clinical trials with biomarkers and give therapeutic opportunity for mCRC patients.

Citations

Citations to this article as recorded by  
  • Tumor mutational burden in colorectal cancer: Implications for treatment
    Adriana Marques, Patrícia Cavaco, Carla Torre, Bruno Sepodes, João Rocha
    Critical Reviews in Oncology/Hematology.2024; 197: 104342.     CrossRef
  • Integrated clinical and genomic models using machine-learning methods to predict the efficacy of paclitaxel-based chemotherapy in patients with advanced gastric cancer
    Yonghwa Choi, Jangwoo Lee, Keewon Shin, Ji Won Lee, Ju Won Kim, Soohyeon Lee, Yoon Ji Choi, Kyong Hwa Park, Jwa Hoon Kim
    BMC Cancer.2024;[Epub]     CrossRef
  • PIK3CA Mutation is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients
    Ju Won Kim, Ah Reum Lim, Ji Young You, Jung Hyun Lee, Sung Eun Song, Nam Kwon Lee, Seung Pil Jung, Kyu Ran Cho, Cheol Yong Kim, Kyong Hwa Park
    Cancer Research and Treatment.2023; 55(2): 531.     CrossRef
  • Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer
    Kyoungmin Lee, Jongwon Lee, Jungmin Choi, Sung Hoon Sim, Jeong Eun Kim, Min Hwan Kim, Yeon Hee Park, Jee Hyun Kim, Su-Jin Koh, Kyong Hwa Park, Myoung Joo Kang, Mi Sun Ahn, Kyoung Eun Lee, Hee-Jun Kim, Hee Kyung Ahn, Han Jo Kim, Keon Uk Park, In Hae Park
    Scientific Reports.2023;[Epub]     CrossRef
  • Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations
    Yoon Ji Choi, Jung Yoon Choi, Ju Won Kim, Ah Reum Lim, Youngwoo Lee, Won Jin Chang, Soohyeon Lee, Jae Sook Sung, Hee-Joon Chung, Jong Won Lee, Eun Joo Kang, Jung Sun Kim, Taekyu Lim, Hye Sook Kim, Yu Jung Kim, Mi Sun Ahn, Young Saing Kim, Ji Hyun Park, Se
    Cancer Research and Treatment.2022; 54(1): 30.     CrossRef
  • Genetic landscape of pancreatic adenocarcinoma patients: a pilot study from Pakistan
    Saleema Mehboob Ali, Yumna Adnan, Zubair Ahmad, Hasnain Ahmed Farooqui, Tabish Chawla, S. M. Adnan Ali
    Molecular Biology Reports.2022; 49(2): 1341.     CrossRef
  • Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group
    Shinkyo Yoon, Miso Kim, Yong Sang Hong, Han Sang Kim, Seung Tae Kim, Jihun Kim, Hongseok Yun, Changhoon Yoo, Hee Kyung Ahn, Hyo Song Kim, In Hee Lee, In-Ho Kim, Inkeun Park, Jae Ho Jeong, Jaekyung Cheon, Jin Won Kim, Jina Yun, Sun Min Lim, Yongjun Cha, Se
    Cancer Research and Treatment.2022; 54(1): 1.     CrossRef
  • Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18–14/KM10B)
    Sung Hoon Sim, Jeong Eun Kim, Min Hwan Kim, Yeon Hee Park, Jee Hyun Kim, Koung Jin Suh, Su-Jin Koh, Kyong Hwa Park, Myoung Joo Kang, Mi Sun Ahn, Kyoung Eun Lee, Hee-Jun Kim, Hee Kyung Ahn, Han Jo Kim, Keon Uk Park, Jae Ho Byun, Jin Hyun Park, Gyeong-Won L
    The Breast.2022; 65: 172.     CrossRef
  • The importance of precision medicine in modern molecular oncology
    Yuanli Wang, Dawu Zheng
    Clinical Genetics.2021; 100(3): 248.     CrossRef
  • Paired analysis of tumor mutation burden calculated by targeted deep sequencing panel and whole exome sequencing in non-small cell lung cancer
    Sehhoon Park, Chung Lee, Bo Mi Ku, Minjae Kim, Woong-Yang Park, Nayoung K. D. Kim, Myung-Ju Ahn
    BMB Reports.2021; 54(7): 386.     CrossRef
  • Evaluation of a Targeted Next-Generation Sequencing Panel for the Non-Invasive Detection of Variants in Circulating DNA of Colorectal Cancer
    Aitor Rodríguez-Casanova, Aida Bao-Caamano, Ramón M. Lago-Lestón, Elena Brozos-Vázquez, Nicolás Costa-Fraga, Isabel Ferreirós-Vidal, Ihab Abdulkader, Yolanda Vidal-Insua, Francisca Vázquez Rivera, Sonia Candamio Folgar, Rafael López-López, Laura Muinelo-R
    Journal of Clinical Medicine.2021; 10(19): 4487.     CrossRef
  • Implications of Intratumor Heterogeneity on Consensus Molecular Subtype (CMS) in Colorectal Cancer
    Saikat Chowdhury, Matan Hofree, Kangyu Lin, Dipen Maru, Scott Kopetz, John Paul Shen
    Cancers.2021; 13(19): 4923.     CrossRef
  • 10,142 View
  • 360 Download
  • 13 Web of Science
  • 12 Crossref
Close layer
Clinical Implication of Concordant or Discordant Genomic Profiling between Primary and Matched Metastatic Tissues in Patients with Colorectal Cancer
Jung Yoon Choi, Sunho Choi, Minhyeok Lee, Young Soo Park, Jae Sook Sung, Won Jin Chang, Ju Won Kim, Yoon Ji Choi, Jin Kim, Dong-Sik Kim, Sung-Ho Lee, Junhee Seok, Kyong Hwa Park, Seon Hahn Kim, Yeul Hong Kim
Cancer Res Treat. 2020;52(3):764-778.   Published online February 16, 2020
DOI: https://doi.org/10.4143/crt.2020.044
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The purpose of this study was to identify the concordant or discordant genomic profiling between primary and matched metastatic tumors in patients with colorectal cancer (CRC) and to explore the clinical implication.
Materials and Methods
Surgical samples of primary and matched metastatic tissues from 158 patients (335 samples) with CRC at Korea University Anam Hospital were evaluated using the Ion AmpliSeq Cancer Hotspot Panel. We compared genetic variants and classified them as concordant, primary-specific, and metastasis-specific variants. We used a combination of principal components analysis and clustering to find genomic groups. Kaplan-Meier curves were used to appraise survival between genomic groups. We used machine learning to confirm the correlation between genetic variants and metastatic sites.
Results
A total of 282 types of deleterious non-synonymous variants were selected for analysis. Of a total of 897 variants, an average of 40% was discordant. Three genomic groups were yielded based on the genomic discrepancy patterns. Overall survival differed significantly between the genomic groups. The poorest group had the highest proportion of concordant KRAS G12V and additional metastasis-specific SMAD4. Correlation analysis between genetic variants and metastatic sites suggested that concordant KRAS mutations would have more disseminated metastases.
Conclusion
Driver gene mutations were mostly concordant; however, discordant or metastasis-specific mutations were present. Clinically, the concordant driver genetic changes with additional metastasis-specific variants can predict poor prognosis for patients with CRC.

Citations

Citations to this article as recorded by  
  • Gene-Mutation-Based Algorithm for Prediction of Treatment Response in Colorectal Cancer Patients
    Heather Johnson, Zahra El-Schich, Amjad Ali, Xuhui Zhang, Athanasios Simoulis, Anette Gjörloff Wingren, Jenny L. Persson
    Cancers.2022; 14(8): 2045.     CrossRef
  • Putative anoikis resistant subpopulations are enriched in lymph node metastases and indicate adverse prognosis in colorectal carcinoma
    Taneli T. Mattila, Madhura Patankar, Juha P. Väyrynen, Kai Klintrup, Jyrki Mäkelä, Anne Tuomisto, Pentti Nieminen, Markus J. Mäkinen, Tuomo J. Karttunen
    Clinical & Experimental Metastasis.2022; 39(6): 883.     CrossRef
  • Clinical Application of Targeted Deep Sequencing in Metastatic Colorectal Cancer Patients: Actionable Genomic Alteration in K-MASTER Project
    Youngwoo Lee, Soohyeon Lee, Jae Sook Sung, Hee-Joon Chung, Ah-reum Lim, Ju Won Kim, Yoon Ji Choi, Kyong Hwa Park, Yeul Hong Kim
    Cancer Research and Treatment.2021; 53(1): 123.     CrossRef
  • Comparison of metastatic castration-resistant prostate cancer in bone with other sites: clinical characteristics, molecular features and immune status
    Zhengquan Xu, Yanhong Ding, Wei Lu, Ke Zhang, Fei Wang, Guanxiong Ding, Jianqing Wang
    PeerJ.2021; 9: e11133.     CrossRef
  • High Concordance of Genomic Profiles between Primary and Metastatic Colorectal Cancer
    Seung Eun Lee, Ha Young Park, Dae-Yong Hwang, Hye Seung Han
    International Journal of Molecular Sciences.2021; 22(11): 5561.     CrossRef
  • Comprehensive Imaging Characterization of Colorectal Liver Metastases
    Drew Maclean, Maria Tsakok, Fergus Gleeson, David J. Breen, Robert Goldin, John Primrose, Adrian Harris, James Franklin
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • 8,399 View
  • 199 Download
  • 6 Web of Science
  • 6 Crossref
Close layer
Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients
Se-Hoon Lee, Boram Lee, Joon Ho Shim, Kwang Woo Lee, Jae Won Yun, Sook-Young Kim, Tae-You Kim, Yeul Hong Kim, Young Hyeh Ko, Hyun Cheol Chung, Chang Sik Yu, Jeeyun Lee, Sun Young Rha, Tae Won Kim, Kyung Hae Jung, Seock-Ah Im, Hyeong-Gon Moon, Sukki Cho, Jin Hyoung Kang, Jihun Kim, Sang Kyum Kim, Han Suk Ryu, Sang Yun Ha, Jong Il Kim, Yeun-Jun Chung, Cheolmin Kim, Hyung-Lae Kim, Woong-Yang Park, Dong-Young Noh, Keunchil Park
Cancer Res Treat. 2019;51(1):211-222.   Published online April 23, 2018
DOI: https://doi.org/10.4143/crt.2018.132
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
With the emergence of next-generation sequencing (NGS) technology, profiling a wide range of genomic alterations has become a possibility resulting in improved implementation of targeted cancer therapy. In Asian populations, the prevalence and spectrum of clinically actionable genetic alterations has not yet been determined because of a lack of studies examining high-throughput cancer genomic data.
Materials and Methods
To address this issue, 1,071 tumor samples were collected from five major cancer institutes in Korea and analyzed using targeted NGS at a centralized laboratory. Samples were either fresh frozen or formalin-fixed, paraffin embedded (FFPE) and the quality and yield of extracted genomic DNA was assessed. In order to estimate the effect of sample condition on the quality of sequencing results, tissue preparation method, specimen type (resected or biopsied) and tissue storage time were compared.
Results
We detected 7,360 non-synonymous point mutations, 1,164 small insertions and deletions, 3,173 copy number alterations, and 462 structural variants. Fifty-four percent of tumors had one or more clinically relevant genetic mutation. The distribution of actionable variants was variable among different genes. Fresh frozen tissues, surgically resected specimens, and recently obtained specimens generated superior sequencing results over FFPE tissues, biopsied specimens, and tissues with long storage duration.
Conclusion
In order to overcome, challenges involved in bringing NGS testing into routine clinical use, a centralized laboratory model was designed that could improve the NGS workflows, provide appropriate turnaround times and control costs with goal of enabling precision medicine.

Citations

Citations to this article as recorded by  
  • Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients
    Fabio Canino, Antonio Tornincasa, Stefania Bettelli, Samantha Manfredini, Monica Barbolini, Luca Moscetti, Claudia Omarini, Angela Toss, Fabio Tamburrano, Giuseppina Antonelli, Federica Baglio, Lorenzo Belluzzi, Giulio Martinelli, Salvatore Natalizio, Orn
    International Journal of Molecular Sciences.2024; 25(5): 2490.     CrossRef
  • Exploring the DNA methylome of Korean patients with colorectal cancer consolidates the clinical implications of cancer-associated methylation markers
    Sejoon Lee, Kil-yong Lee, Ji-Hwan Park, Duck-Woo Kim, Heung-Kwon Oh, Seong-Taek Oh, Jongbum Jeon, Dongyoon Lee, Soobok Joe, Hoang Bao Khanh Chu, Jisun Kang, Jin-Young Lee, Sheehyun Cho, Hyeran Shim, Si-Cho Kim, Hong Seok Lee, Young-Joon Kim, Jin Ok Yang,
    BMB Reports.2024; 57(3): 161.     CrossRef
  • Establishing molecular pathology curriculum for pathology trainees and continued medical education: a collaborative work from the Molecular Pathology Study Group of the Korean Society of Pathologists
    Jiwon Koh, Ha Young Park, Jeong Mo Bae, Jun Kang, Uiju Cho, Seung Eun Lee, Haeyoun Kang, Min Eui Hong, Jae Kyung Won, Youn-La Choi, Wan-Seop Kim, Ahwon Lee
    Journal of Pathology and Translational Medicine.2023; 57(5): 265.     CrossRef
  • Quality and Quantity of Nucleic Acids Extracted from Formalin-Fixed Paraffin-Embedded Lymphoma Biopsies from Nigerian Archived Biopsy
    IC Uzoma, IA Taiwo, NI Ugwu, MA Durosinmi, O Akinloye
    Nigerian Journal of Clinical Practice.2023; 26(12): 1854.     CrossRef
  • Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group
    Shinkyo Yoon, Miso Kim, Yong Sang Hong, Han Sang Kim, Seung Tae Kim, Jihun Kim, Hongseok Yun, Changhoon Yoo, Hee Kyung Ahn, Hyo Song Kim, In Hee Lee, In-Ho Kim, Inkeun Park, Jae Ho Jeong, Jaekyung Cheon, Jin Won Kim, Jina Yun, Sun Min Lim, Yongjun Cha, Se
    Cancer Research and Treatment.2022; 54(1): 1.     CrossRef
  • State legislative trends related to biomarker testing
    Gelareh Sadigh, Hilary Gee Goeckner, Ella A. Kazerooni, Bruce E. Johnson, Robert A. Smith, Devon V. Adams, Ruth C. Carlos
    Cancer.2022; 128(15): 2865.     CrossRef
  • Clinical Application of Next-Generation Sequencing in Patients With Breast Cancer: Real-World Data
    Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Heechul Shin, Eunyoung Kang, Eun-Kyu Kim, Sejoon Lee, Ji Won Woo, Hee Young Na, Soomin Ahn, Bum-Sup Jang, In Ah Kim, So Yeon Park, Jee Hyun Kim
    Journal of Breast Cancer.2022; 25(5): 366.     CrossRef
  • Small-Cell Lung Cancer: Is the Black Box Finally Opening Up?
    Birgitta I. Hiddinga, Klaas Kok
    Cancers.2021; 13(2): 236.     CrossRef
  • Real‐world utility of next‐generation sequencing for targeted gene analysis and its application to treatment in lung adenocarcinoma
    Jwa Hoon Kim, Shinkyo Yoon, Dae Ho Lee, Se Jin Jang, Sung‐Min Chun, Sang‐We Kim
    Cancer Medicine.2021; 10(10): 3197.     CrossRef
  • Actionability evaluation of biliary tract cancer by genome transcriptome analysis and Asian cancer knowledgebase
    Yuki Okawa, Nobutaka Ebata, Nayoung K.D. Kim, Masashi Fujita, Kazuhiro Maejima, Shota Sasagawa, Toru Nakamura, Woong-Yang Park, Satoshi Hirano, Hidewaki Nakagawa
    Oncotarget.2021; 12(15): 1540.     CrossRef
  • Development and Validation of Targeted Gene Sequencing Panel Based Companion Diagnostic for Korean Patients with Solid Tumors
    Byung-Joo Min, Woo Seung Lee, Myung-Eui Seo, Kye-Hwa Lee, Seung-Yong Jeong, Ja-Lok Ku, Yeul Hong Kim, Sang-Won Shin, Ju Han Kim
    Cancers.2021; 13(20): 5112.     CrossRef
  • Junction Location Identifier (JuLI)
    Hyun-Tae Shin, Nayoung K.D. Kim, Jae Won Yun, Boram Lee, Sungkyu Kyung, Ki-Wook Lee, Daeun Ryu, Jinho Kim, Joon Seol Bae, Donghyun Park, Yoon-La Choi, Se-Hoon Lee, Myung-Ju Ahn, Keunchil Park, Woong-Yang Park
    The Journal of Molecular Diagnostics.2020; 22(3): 304.     CrossRef
  • Simple prediction model for homologous recombination deficiency in breast cancers in adolescents and young adults
    Tomoko Watanabe, Takayuki Honda, Hirohiko Totsuka, Masayuki Yoshida, Maki Tanioka, Kouya Shiraishi, Yoko Shimada, Eri Arai, Mineko Ushiama, Kenji Tamura, Teruhiko Yoshida, Yae Kanai, Takashi Kohno
    Breast Cancer Research and Treatment.2020; 182(2): 491.     CrossRef
  • 14,434 View
  • 467 Download
  • 14 Web of Science
  • 13 Crossref
Close layer
Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer
Kyu-pyo Kim, Jeong-Eun Kim, Yong Sang Hong, Sung-Min Ahn, Sung Min Chun, Seung-Mo Hong, Se Jin Jang, Chang Sik Yu, Jin Cheon Kim, Tae Won Kim
Cancer Res Treat. 2017;49(1):161-167.   Published online July 4, 2016
DOI: https://doi.org/10.4143/crt.2015.490
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Although the mutation status of KRAS is highly concordant in primary and metastatic lesions, it has not been generalized to other major pathway genes.
Materials and Methods
In this study, 41 genes were evaluated and the mutational profiles were compared in 46 colorectal cancer patients with paired surgical specimens of primary and metastatic lesions: synchronous (n=27) and metachronous (n=19) lesions. A high-throughput mass spectrometry-based genotyping platform validated by orthogonal chemistry, OncoMap v.4.4, was used to evaluate the formalin-fixed, paraffin-embedded surgical specimens. The patients’ demographics, tumor characteristics, and microsatellite instability status were analyzed by a retrospective chart review.
Results
In this study,with OncoMap, mutationswere identified in 80.4% of patientswith the following frequency: KRAS (39.1%), TP53 (28.3%), APC (28.3%), PIK3CA (6.5%), BRAF (6.5%), and NRAS (4.3%). Although 19.6% (9/46) of the patients showed no gene mutations, 43.5% (20/46) and 37.0% (17/46) had mutations in one and two or more genes, respectively. The synchronous and metachronous lesions showed similar mutational profiles. Paired samples between primary and metastatic tumors differed in 7.4% (2/27) and 10.5% (2/19) for synchronous and metachronous according to OncoMap.
Conclusion
These findings indicate the major pathway genes, including KRAS, TP53, APC, PIK3CA, BRAF, and NRAS, are often concordant between the primary and metastatic lesions regardless of the temporal relationship of metastasis.

Citations

Citations to this article as recorded by  
  • Mutation characteristics and molecular evolution of ovarian metastasis from gastric cancer and potential biomarkers for paclitaxel treatment
    Pengfei Yu, Can Hu, Guangyu Ding, Xiaoliang Shi, Jingli Xu, Yang Cao, Xiangliu Chen, Wei Wu, Qi Xu, Jingquan Fang, Xingmao Huang, Shaohua Yuan, Hui Chen, Zhizheng Wang, Ling Huang, Fei Pang, Yian Du, Xiangdong Cheng
    Nature Communications.2024;[Epub]     CrossRef
  • The varied clonal trajectory of liver and lung metastases of colorectal cancer
    Ofer N. Gofrit, Ben Gofrit, S. Nahum Goldberg, Aron Popovtzer, Jacob Sosna, Ayala Hubert
    Advances in Cancer Biology - Metastasis.2024; 11: 100122.     CrossRef
  • Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Triple-Negative Breast Cancers
    Jaspreet Kaur, Darshan S. Chandrashekar, Zsuzsanna Varga, Bettina Sobottka, Emiel Janssen, Khanjan Gandhi, Jeanne Kowalski, Umay Kiraz, Sooryanarayana Varambally, Ritu Aneja
    Genes.2023; 14(9): 1690.     CrossRef
  • The different clonal origins of metachronous and synchronous metastases
    Ofer N. Gofrit, Ben Gofrit, Yuval Roditi, Aron Popovtzer, Steve Frank, Jacob Sosna, Marina Orevi, S. Nahum Goldberg
    Journal of Cancer Research and Clinical Oncology.2023; 149(13): 11085.     CrossRef
  • Inoperable de novo metastatic colorectal cancer with primary tumour in situ: Evaluating discordant responses to upfront systemic therapy of the primary tumours and metastatic sites and complications arising from primary tumours (experiences from an Irish
    Ruba Hamed, Sam Marks, Helen Mcelligott, Roshni Kalachand, Hawa Ibrahim, Said Atyani, Greg Korpanty, Nemer Osman
    Molecular and Clinical Oncology.2021;[Epub]     CrossRef
  • Association of DNA repair gene polymorphisms with colorectal cancer risk and treatment outcomes
    Fawaz N. Al-Shaheri, Kamal M. Al-Shami, Eshrak H. Gamal, Amjad A. Mahasneh, Nehad M. Ayoub
    Experimental and Molecular Pathology.2020; 113: 104364.     CrossRef
  • High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases
    Tuva Høst Brunsell, Anita Sveen, Bjørn Atle Bjørnbeth, Bård I. Røsok, Stine Aske Danielsen, Kristoffer Watten Brudvik, Kaja C.G. Berg, Bjarne Johannessen, Vanja Cengija, Andreas Abildgaard, Marianne Grønlie Guren, Arild Nesbakken, Ragnhild A. Lothe
    Clinical Colorectal Cancer.2020; 19(1): e26.     CrossRef
  • Case report: recurrent pituitary adenoma has increased load of somatic variants
    Raitis Peculis, Inga Balcere, Ilze Radovica-Spalvina, Ilze Konrade, Olivija Caune, Kaspars Megnis, Vita Rovite, Janis Stukens, Jurijs Nazarovs, Austra Breiksa, Aigars Kiecis, Ivars Silamikelis, Valdis Pirags, Janis Klovins
    BMC Endocrine Disorders.2020;[Epub]     CrossRef
  • Transcriptomic analysis by RNA sequencing characterises malignant progression of canine insulinoma from normal tissue to metastatic disease
    Y. Capodanno, F. O. Buishand, L. Y. Pang, J. Kirpensteijn, J. A. Mol, R. Elders, D. J. Argyle
    Scientific Reports.2020;[Epub]     CrossRef
  • Genetic Alterations of Metastatic Colorectal Cancer
    Ugo Testa, Germana Castelli, Elvira Pelosi
    Biomedicines.2020; 8(10): 414.     CrossRef
  • Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers
    Yanglong Chen, Ying Lu, Yuting Ke, Yanling Li
    Medicine.2019; 98(39): e17221.     CrossRef
  • Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer
    Camille Evrard, Gaëlle Tachon, Violaine Randrian, Lucie Karayan-Tapon, David Tougeron
    Cancers.2019; 11(10): 1567.     CrossRef
  • Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting
    William Hankey, Wendy L. Frankel, Joanna Groden
    Cancer and Metastasis Reviews.2018; 37(1): 159.     CrossRef
  • Colorectal Cancer: Genetic Abnormalities, Tumor Progression, Tumor Heterogeneity, Clonal Evolution and Tumor-Initiating Cells
    Ugo Testa, Elvira Pelosi, Germana Castelli
    Medical Sciences.2018; 6(2): 31.     CrossRef
  • Comparison of genetic profiles among primary lung tumor, metastatic lymph nodes and circulating tumor DNA in treatment-naïve advanced non-squamous non-small cell lung cancer patients
    Fangfang Xie, Yujun Zhang, Xiaowei Mao, Xiaoxuan Zheng, Han Han-Zhang, Junyi Ye, Ruiying Zhao, Xueyan Zhang, Jiayuan Sun
    Lung Cancer.2018; 121: 54.     CrossRef
  • Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer
    Georgios Antonios Margonis, Stefan Buettner, Nikolaos Andreatos, Yuhree Kim, Doris Wagner, Kazunari Sasaki, Andrea Beer, Christoph Schwarz, Inger Marie Løes, Maria Smolle, Carsten Kamphues, Jin He, Timothy M. Pawlik, Klaus Kaczirek, George Poultsides, Per
    JAMA Surgery.2018; 153(7): e180996.     CrossRef
  • Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?
    Chiara Molinari, Giorgia Marisi, Alessandro Passardi, Laura Matteucci, Giulia De Maio, Paola Ulivi
    International Journal of Molecular Sciences.2018; 19(12): 3733.     CrossRef
  • 10,501 View
  • 279 Download
  • 20 Web of Science
  • 17 Crossref
Close layer
Review Article
Systems Biology Approaches to Decoding the Genome of Liver Cancer
Ju-Seog Lee, Ji Hoon Kim, Yun-Yong Park, Gordon B. Mills
Cancer Res Treat. 2011;43(4):205-211.   Published online December 27, 2011
DOI: https://doi.org/10.4143/crt.2011.43.4.205
AbstractAbstract PDFPubReaderePub
Molecular classification of cancers has been significantly improved patient outcomes through the implementation of treatment protocols tailored to the abnormalities present in each patient's cancer cells. Breast cancer represents the poster child with marked improvements in outcome occurring due to the implementation of targeted therapies for estrogen receptor or human epidermal growth factor receptor-2 positive breast cancers. Important subtypes with characteristic molecular features as potential therapeutic targets are likely to exist for all tumor lineages including hepatocellular carcinoma (HCC) but have yet to be discovered and validated as targets. Because each tumor accumulates hundreds or thousands of genomic and epigenetic alterations of critical genes, it is challenging to identify and validate candidate tumor aberrations as therapeutic targets or biomarkers that predict prognosis or response to therapy. Therefore, there is an urgent need to devise new experimental and analytical strategies to overcome this problem. Systems biology approaches integrating multiple data sets and technologies analyzing patient tissues holds great promise for the identification of novel therapeutic targets and linked predictive biomarkers allowing implementation of personalized medicine for HCC patients.

Citations

Citations to this article as recorded by  
  • Systems Challenges of Hepatic Carcinomas: A Review
    Dhatri Madduru, Johny Ijaq, Sujata Dhar, Saumyadip Sarkar, Naresh Poondla, Partha S. Das, Silvia Vasquez, Prashanth Suravajhala
    Journal of Clinical and Experimental Hepatology.2019; 9(2): 233.     CrossRef
  • Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease
    Yuan Tian, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, Alfred Sze-Lok Cheng
    Seminars in Cancer Biology.2013; 23(6): 471.     CrossRef
  • The Impact of Network Medicine in Gastroenterology and Hepatology
    György Baffy
    Clinical Gastroenterology and Hepatology.2013; 11(10): 1240.     CrossRef
  • 10,077 View
  • 64 Download
  • 3 Crossref
Close layer
Erratum
ERRATUM: Correction for Incorrect Citation of Reference and Wording in a Table
Cancer Res Treat. 2011;43(3):204-204.   Published online September 30, 2011
DOI: https://doi.org/10.4143/crt.2011.43.3.204
AbstractAbstract PDFPubReaderePub
No abstract available.
  • 6,547 View
  • 42 Download
Close layer
Review Article
The Role of HPV E6 and E7 Oncoproteins in HPV-associated Cervical Carcinogenesis
Eun-Kyoung Yim, Jong-Sup Park
Cancer Res Treat. 2005;37(6):319-324.   Published online December 31, 2005
DOI: https://doi.org/10.4143/crt.2005.37.6.319
AbstractAbstract PDFPubReaderePub

Cervical cancer is one of the leading world causes of cancer morbidity and mortality in woman, with more than 98% related to a human papillomavirus (HPV) infection origin. Infection with specific subtypes of HPV has been strongly implicated in cervical carcinogenesis. The identification and functional verification of host proteins associated with HPV E6 and E7 oncoproteins may provide useful information in understanding cervical carcinogenesis and the development of cervical cancer-specific markers. The advent of functional genomics and proteomics has provided hope of discovering novel biological markers for use in the screening, early diagnosis, prognostication and prediction of response to therapy. Herein, we review the studies where the profiles of host proteins associated with HPV E6 and E7 oncoproteins in cervical cancer were generated.

Citations

Citations to this article as recorded by  
  • Downregulation of LAMB3 Altered the Carcinogenic Properties of Human Papillomavirus 16-Positive Cervical Cancer Cells
    Warattaya Wattanathavorn, Masahide Seki, Yutaka Suzuki, Supranee Buranapraditkun, Nakarin Kitkumthorn, Thanayod Sasivimolrattana, Parvapan Bhattarakosol, Arkom Chaiwongkot
    International Journal of Molecular Sciences.2024; 25(5): 2535.     CrossRef
  • It Is All about Probiotics to Control Cervical Cancer
    Sumel Ashique, Abdul Faruk, Farhan Jalees Ahmad, Tasneem Khan, Neeraj Mishra
    Probiotics and Antimicrobial Proteins.2024; 16(3): 979.     CrossRef
  • Down-regulation of human papillomavirus E6 oncogene and antiproliferative effect of Schisandra chinensis and Pueraria lobata natural extracts on Hela cell line
    Andrés Cardona-Mendoza, Angela Fonseca-Benitez, Diana Marcela Buitrago, Ericsson Coy-Barrera, Sandra J. Perdomo
    Journal of Ethnopharmacology.2024; 319: 117225.     CrossRef
  • HPV16 E6/E7-mediated regulation of PiwiL1 expression induces tumorigenesis in cervical cancer cells
    Midhunaraj Kunnummal, Pooja Sherly Raveendran, Budhaditya Basu, Sheri Vidya Rani, Riya Ann Paul, Krithiga Kuppusamy, Mary Angelin, Joby Issac, Jackson James, Ani V. Das
    Cellular Oncology.2024; 47(3): 917.     CrossRef
  • Cis‐regulatory effect of HPV integration is constrained by host chromatin architecture in cervical cancers
    Anurag Kumar Singh, Kaivalya Walavalkar, Daniele Tavernari, Giovanni Ciriello, Dimple Notani, Radhakrishnan Sabarinathan
    Molecular Oncology.2024; 18(5): 1189.     CrossRef
  • The microbiome and gynecologic cancer: cellular mechanisms and clinical applications
    Julia Chalif, Heather Wang, Daniel Spakowicz, Allison Quick, Elizabeth K Arthur, David O’Malley, Laura M Chambers
    International Journal of Gynecological Cancer.2024; 34(2): 317.     CrossRef
  • Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case‐cohort study
    Christiana Kartsonaki, Pang Yao, Julia Butt, Rima Jeske, Catherine de Martel, Martyn Plummer, Dianjianyi Sun, Sarah Clark, Robin G. Walters, Yiping Chen, Jun Lv, Canqing Yu, Michael Hill, Richard Peto, Liming Li, Tim Waterboer, Zhengming Chen, Iona Y. Mil
    International Journal of Cancer.2024; 154(8): 1423.     CrossRef
  • Serum oxidative biomarkers associated with genital HPV infection and cervical lesions in women
    Hui‐Yi Lin, Xiaodan Zhu, Harun Or Rashid Mazumder, Martin Ronis, Kim Brint Pedersen, Michael Hagensee
    Journal of Medical Virology.2024;[Epub]     CrossRef
  • Combined amplification-based single-molecule fluorescence in situ hybridization with immunofluorescence for simultaneous in situ detection of RNAs and proteins
    Yinghui Qiu, Kaipeng Wei, Hui Lin, Yanxiu Liu, Chen Lin, Rongqin Ke
    Biochemical and Biophysical Research Communications.2024; 696: 149508.     CrossRef
  • PARP1, DIDO3, and DHX9 Proteins Mutually Interact in Mouse Fibroblasts, with Effects on DNA Replication Dynamics, Senescence, and Oncogenic Transformation
    Agnes Fütterer, Sara Rodriguez-Acebes, Juan Méndez, Julio Gutiérrez, Carlos Martínez-A
    Cells.2024; 13(2): 159.     CrossRef
  • Technologies of gene editing and related clinical trials for the treatment of genetic and acquired diseases: a systematic review
    Wessam Sharaf-Eldin
    Egyptian Journal of Medical Human Genetics.2024;[Epub]     CrossRef
  • The role of viruses in cancer progression versus cancer treatment: A dual paradigm
    Somya Ranjan Dash, Anushka Kundu, Chanakya Nath Kundu
    Life Sciences.2024; 341: 122506.     CrossRef
  • Epigallocatechin Gallate for the Treatment of Benign and Malignant Gynecological Diseases—Focus on Epigenetic Mechanisms
    Marta Włodarczyk, Michał Ciebiera, Grażyna Nowicka, Tomasz Łoziński, Mohamed Ali, Ayman Al-Hendy
    Nutrients.2024; 16(4): 559.     CrossRef
  • Unveiling HPV's hidden link: Cardiovascular diseases and the viral intrigue
    Preyangsee Dutta, Dwaipayan Saha, Mrudul Earle, Chandra Prakash Prasad, Mayank Singh, Mrinalini Darswal, Vipul Aggarwal, Nitish Naik, Rakesh Yadav, Abhishek Shankar, Abhijit Chakraborty
    Indian Heart Journal.2024; 76(1): 1.     CrossRef
  • Regulation and tumor‐suppressive function of the miR‐379/miR‐656 (C14MC) cluster in cervical cancer
    Sriharikrishnaa Srinath, Padacherri Vethil Jishnu, Vinay Koshy Varghese, Vaibhav Shukla, Divya Adiga, Sandeep Mallya, Sanjiban Chakrabarty, Krishna Sharan, Deeksha Pandey, Aniruddha Chatterjee, Shama Prasada Kabekkodu
    Molecular Oncology.2024; 18(6): 1608.     CrossRef
  • Comprehensive analysis of a novel subtype of immune microenvironment-derived HPV-infected colorectal cancer
    Jianlong Zhou, Yongfeng Liu, Yucheng Zhang, Fa Ling, Jiabin Zheng, Xueqing Yao, Zejian Lyu, Huolun Feng, Yong Li
    Microbes and Infection.2024; 26(4): 105315.     CrossRef
  • Evolution of Pathological Techniques for the Screening of Cervical Cancer: A Comprehensive Review
    Priya B Chatterjee, Snehlata R Hingway, Kishor M Hiwale
    Cureus.2024;[Epub]     CrossRef
  • Therapeutic Response to Treatment of a Papillomatous Ocular Surface Squamous Neoplasia With Intramuscular Human Papillomavirus Vaccine
    Mike Zein, Sofia De Arrigunaga, Mona M. Amer, Anat Galor, Anna J. Nichols, Tim Ioannides, Sander R. Dubovy, Carol L. Karp
    Cornea.2024;[Epub]     CrossRef
  • BRCA1 deficiency enhances the aggressiveness of breast cancer cells expressing HPV16 oncoproteins
    Jariya Sangthong, Chanitra Thuwajit, Laran T. Jensen, Waraporn Komyod, Jirundon Yuvaniyama, Mathurose Ponglikitmongkol
    Biology of the Cell.2024;[Epub]     CrossRef
  • Exploring the Relationship between Ovarian Cancer and Genital Microbiota: A Systematic Review and Meta-Analysis
    Vito Andrea Capozzi, Giosuè Giordano Incognito, Elisa Scarpelli, Marco Palumbo, Cinzia Lucia Randazzo, Alessandra Pino, Marco La Verde, Carlo Ronsini, Gaetano Riemma, Michela Gaiano, Paola Romeo, Vittorio Palmara, Roberto Berretta, Stefano Cianci
    Journal of Personalized Medicine.2024; 14(4): 351.     CrossRef
  • Virus-like Particles for Disease Diagnosis and Drug Delivery Applications
    Rishav Sharma, Rishabha Malviya
    Current Nanoscience.2024; 20(5): 613.     CrossRef
  • Biplex quantitative PCR to detect transcriptionally active human papillomavirus 16 from patient saliva
    Fiona Deutsch, Dayna Sais, Ni Keatinge, Meredith Hill, Ngoc Ha Tran, Michael Elliott, Nham Tran
    BMC Cancer.2024;[Epub]     CrossRef
  • Biochemical and toxicity evaluation of Retama sphaerocarpa extracts and in-silico investigation of phenolic compounds as potential inhibitors against HPV16 E6 oncoprotein
    Soumia Moujane, Ismail Bouadid, Aziz Bouymajane, Filali Zegzouti Younes, Mohamed Benlyas, Bouachrine Mohammed, Francesco Cacciola, Roberto Laganà Vinci, Alessia Tropea, Luigi Mondello, Ammar B. Altemimi, Mohamed Eddouks, Benaissa Moualij
    Fitoterapia.2024; 175: 105923.     CrossRef
  • Viruses in glioblastoma: an update on evidence and clinical trials
    Bavani Gunasegaran, Caroline L. Ashley, Felix Marsh-Wakefield, Gilles J. Guillemin, Benjamin Heng
    BJC Reports.2024;[Epub]     CrossRef
  • Ubiquitin-specific protease 7 inhibitors reveal a differentiated mechanism of p53-driven anti-cancer activity
    Alan S. Futran, Tao Lu, Katherine Amberg-Johnson, Jiayi Xu, Xiaoxiao Yang, Saidi He, Sarah Boyce, Jeffrey A. Bell, Robert Pelletier, Takao Suzuki, Xianhai Huang, Heng Qian, Liping Fang, Li Xing, Zhaowu Xu, Stephen E. Kurtz, Jeffrey W. Tyner, Wayne Tang, T
    iScience.2024; 27(5): 109693.     CrossRef
  • Emerging biomarkers and molecular targets for precision medicine in cervical cancer
    Pankaj Garg, Madhu Krishna, Ayalur Raghu Subbalakshmi, Sravani Ramisetty, Atish Mohanty, Prakash Kulkarni, David Horne, Ravi Salgia, Sharad S. Singhal
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2024; 1879(3): 189106.     CrossRef
  • Unfurling the functional association between long intergenic noncoding RNAs (lincRNAs) and HPV16-related cervical cancer pathogenesis through weighted gene co-expression network analysis of differentially expressed lincRNAs and coding genes
    Abarna Sinha, Sahana Ghosh, Abhisikta Ghosh, Arnab Ghosh, Sonia Mathai, Jaydip Bhaumik, Asima Mukhopadhyay, Arindam Maitra, Nidhan K Biswas, Sharmila Sengupta
    Carcinogenesis.2024; 45(7): 451.     CrossRef
  • Two Lineages of Papillomaviruses Identified from Caracals (Caracal caracal) in South Africa
    Simona Kraberger, Laurel E. K. Serieys, Gabriella R. M. Leighton, Matthew D. De Koch, John S. Munday, Jacqueline M. Bishop, Arvind Varsani
    Viruses.2024; 16(5): 701.     CrossRef
  • Molecular Typing of Human Leukocyte Antigen-Class I (HLA-A, HLA-B) & Human Leukocyte Antigen-Class II (HLA-DR) in Carcinoma Cervix and Its Association with Staging
    Sumanta Das, Mukul Singh, Anjali Sharma, R. Naveen Kumar, Adil Aziz Khan
    Indian Journal of Gynecologic Oncology.2024;[Epub]     CrossRef
  • Tumor-Derived Antigenic Peptides as Potential Cancer Vaccines
    Stanislav Sotirov, Ivan Dimitrov
    International Journal of Molecular Sciences.2024; 25(9): 4934.     CrossRef
  • CRL4-DCAF1 Ubiquitin Ligase Dependent Functions of HIV Viral Protein R and Viral Protein X
    Ashley Dobransky, Mary Root, Nicholas Hafner, Matty Marcum, H. John Sharifi
    Viruses.2024; 16(8): 1313.     CrossRef
  • Impact of human papillomavirus types on uterine cervical neoplasia
    Ayumi Taguchi, Daisuke Yoshimoto, Misako Kusakabe, Satoshi Baba, Akira Kawata, Yuichiro Miyamoto, Mayuyo Mori, Kenbun Sone, Yasushi Hirota, Yutaka Osuga
    Journal of Obstetrics and Gynaecology Research.2024; 50(8): 1283.     CrossRef
  • Quantification of HPV16 E7 Oncoproteins in Urine Specimens from Women with Cervical Intraepithelial Neoplasia
    Daiki Makioka, Mikio Inada, Masayuki Awano, Ema Saito, Takuya Shinoda, Satoko Abe, Teruki Yoshimura, Martin Müller, Toshiyuki Sasagawa, Etsuro Ito
    Microorganisms.2024; 12(6): 1205.     CrossRef
  • Assessing bias in the causal role of HPV in oral cancer: A systematic review and meta‐analysis
    Gagandeep Kaur, Tami Yap, Rishi Ramani, Michael McCullough, Ankur Singh
    Oral Diseases.2024; 30(8): 5379.     CrossRef
  • Current status and future directions for the development of human papillomavirus vaccines
    Rui Wang, Hongpeng Huang, Chulin Yu, Xuefeng Li, Yang Wang, Liangzhi Xie
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Exosome‐based therapy and targeted PROTAC delivery: A new nanomedicine frontier for HPV‐mediated cervical cancer treatment
    Nobendu Mukerjee, Swastika Maitra, Arabinda Ghosh
    Clinical and Translational Discovery.2024;[Epub]     CrossRef
  • Human papillomavirus‐16 E6‐positive cervical cancer attenuated by potent 2‐(4‐biphenylyl)‐N‐(1‐ethyl‐4‐piperidinyl) acetamide second‐generation analogs with improved binding affinity
    Ashish Kumar
    Biotechnology and Applied Biochemistry.2024; 71(6): 1428.     CrossRef
  • Transforming growth factor-β micro-environment mediated immune cell functions in cervical cancer
    Jayapradha Gnanagurusamy, Sneha Krishnamoorthy, Sridhar Muthusami
    International Immunopharmacology.2024; 140: 112837.     CrossRef
  • Harnessing virulence factor-derived peptides for innovative oral cancer treatment
    Karthikeyan Kandaswamy, Ajay Guru
    Natural Product Research.2024; : 1.     CrossRef
  • Oncoviral Infections and Small Extracellular Vesicles
    Łukasz Ważny, Theresa L. Whiteside, Monika Pietrowska
    Viruses.2024; 16(8): 1291.     CrossRef
  • Therapeutic Strategies in Advanced Cervical Cancer Detection, Prevention and Treatment
    Xolisiwe Sebutsoe, Nrateng Tsotetsi, Zodwa Jantjies, Portia Pheladi Raphela-Choma, Mpho Choene, lesetja R Motadi
    OncoTargets and Therapy.2024; Volume 17: 785.     CrossRef
  • Bovine papillomavirus gene expression and inflammatory pathway activation vary between equine sarcoid tumour subtypes
    Nicholas J. Parkinson, Abby Ward, Alexandra J. Malbon, Richard J.M. Reardon, Padraig G. Kelly
    Veterinary Immunology and Immunopathology.2024; 277: 110838.     CrossRef
  • Small non-coding RNAs as diagnostic, prognostic and predictive biomarkers of gynecological cancers: an update
    Marios A. Diamantopoulos, Panagiotis G. Adamopoulos, Andreas Scorilas
    Expert Review of Molecular Diagnostics.2024; 24(11): 979.     CrossRef
  • The role of transforming growth factor β in cervical carcinogenesis
    Kleber Paiva Trugilo, Guilherme Cesar Martelossi Cebinelli, Eliza Pizarro Castilha, Mariane Ricciardi da Silva, Fernanda Costa Brandão Berti, Karen Brajão de Oliveira
    Cytokine & Growth Factor Reviews.2024; 80: 12.     CrossRef
  • A Self-Amplifying Human Papillomavirus 16 Vaccine Candidate Delivered by Tobacco Mosaic Virus-Like Particles
    Sweta Karan, Jessica Fernanda Affonso De Oliveira, Miguel A. Moreno-Gonzalez, Nicole F. Steinmetz
    ACS Applied Bio Materials.2024; 7(11): 7675.     CrossRef
  • A State‐of‐the‐Art Review on the Recent Advances in Exosomes in Oncogenic Virus
    Fatemeh Ebrahimi, Ali Modaresi Movahedi, Mohammad Sabbaghian, Vahdat Poortahmasebi
    Health Science Reports.2024;[Epub]     CrossRef
  • Association between mutant E6 and E7 Human Papilloma Virus Type 16 oncogenes with cyclin D1 expression in cervical cancer: Observational study in Bali
    I Nyoman Bayu Mahendra, I Nyoman Gede Budiana, I Gede Mega Putra, Anom Suardika, Anak Agung Gede Putra Wiradnyana, Alisza Novrita Sari
    F1000Research.2023; 12: 257.     CrossRef
  • Human papillomavirus infection, cervical cancer and the less explored role of trace elements
    Anne Boyina Sravani, Vivek Ghate, Shaila Lewis
    Biological Trace Element Research.2023; 201(3): 1026.     CrossRef
  • Viral subversion of the cell polarity regulator Scribble
    Airah Javorsky, Patrick O. Humbert, Marc Kvansakul
    Biochemical Society Transactions.2023;[Epub]     CrossRef
  • High nuclear expression of DNMT1 in correlation with inactivation of TET1 portray worst prognosis among the cervical carcinoma patients: clinical implications
    Priyanka Dutta, Mukta Basu, Anup Roy, Ranajit Kumar Mandal, Chinmay Kumar Panda
    Journal of Molecular Histology.2023; 54(1): 89.     CrossRef
  • p15INK4B is an alternative marker of senescent tumor cells in colorectal cancer
    Soon Sang Park, Young-Kyoung Lee, So Hyun Park, Su Bin Lim, Yong Won Choi, Jun Sang Shin, Young Hwa Kim, Jang-Hee Kim, Tae Jun Park
    Heliyon.2023; 9(2): e13170.     CrossRef
  • Evaluation of the proteomic landscape of HPV E7‑induced alterations in human keratinocytes reveal therapeutically relevant pathways for cervical cancer
    Sivasangkary Gandhi, Muhammad Fazril Mohamad Razif, Shatrah Othman, Sajib Chakraborty, Nurshamimi Nor Rashid
    Molecular Medicine Reports.2023;[Epub]     CrossRef
  • Immune Environment and Immunotherapy in Endometrial Carcinoma and Cervical Tumors
    Alexandra Lainé, Andrea M. Gonzalez-Lopez, Uzma Hasan, Ryotaro Ohkuma, Isabelle Ray-Coquard
    Cancers.2023; 15(7): 2042.     CrossRef
  • Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches
    Faheem Ahmed, In Suk Kang, Kyung Hwan Kim, Arun Asif, Chethikkattuveli Salih Abdul Rahim, Anupama Samantasinghar, Fida Hussain Memon, Kyung Hyun Choi
    Journal of Medical Virology.2023;[Epub]     CrossRef
  • Protein–DNA Interactions Regulate Human Papillomavirus DNA Replication, Transcription, and Oncogenesis
    Roxanne Evande, Anshul Rana, Esther E. Biswas-Fiss, Subhasis B. Biswas
    International Journal of Molecular Sciences.2023; 24(10): 8493.     CrossRef
  • Histopathologic and molecular characterization of Erethizon dorsatum papillomavirus 1 and Erethizon dorsatum papillomavirus 2 infection in North American porcupines (Erethizon dorsatum)
    Zoe E. Mack, Leonardo C. Caserta, Randall W. Renshaw, Shotaro Nakagun, Rhea S. Gerdes, Diego G. Diel, Sara E. Childs-Sanford, Jeanine Peters-Kennedy
    Veterinary Pathology.2023; 60(6): 898.     CrossRef
  • Whole-Genome Doubling as a source of cancer: how, when, where, and why?
    Natalia Sanz-Gómez, María González-Álvarez, Javier De Las Rivas, Guillermo de Cárcer
    Frontiers in Cell and Developmental Biology.2023;[Epub]     CrossRef
  • Retrospective Phylodynamic and Phylogeographic Analysis of the Human Papillomavirus 16 E6 Gene in the Mediterranean Region
    Oussama Souiai, Ameni Sallemi
    Bioinformatics and Biology Insights.2023;[Epub]     CrossRef
  • MicroRNAs as Potential Biomarkers in Gynecological Cancers
    Joanna Miśkiewicz, Aleksandra Mielczarek-Palacz, Joanna Magdalena Gola
    Biomedicines.2023; 11(6): 1704.     CrossRef
  • Impact of Dietary Quality on Genital Oncogenic Human Papillomavirus Infection in Women
    Hui-Yi Lin, Qiufan Fu, Tung-sung Tseng, Xiaodan Zhu, Krzysztof Reiss, L Joseph Su, Michael E Hagensee
    The Journal of Infectious Diseases.2023; 228(10): 1385.     CrossRef
  • Prevalence of P16 Immunohistochemistry Positive Staining and Its Correlation to Clinical and Radiological Staging of Squamous Cell Carcinoma of the Cervix
    Hossam H. El Sokkary, Eman Sheta
    The Journal of Obstetrics and Gynecology of India.2023; 73(S1): 142.     CrossRef
  • HPV-associated cancers: insights into the mechanistic scenario and latest updates
    Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Rama Jayaraj, Ramkumar Katturajan, Sandra Kannampuzha, Reshma Murali, Arunraj Namachivayam, Sabina Evan Prince, Balachandar Vellingiri, Abhijit Dey, Kaviyarasi Renu
    Medical Oncology.2023;[Epub]     CrossRef
  • Genome editing mRNA nanotherapies inhibit cervical cancer progression and regulate the immunosuppressive microenvironment for adoptive T-cell therapy
    Kaijian Ling, Yin Dou, Neng Yang, Li Deng, Yanzhou Wang, Yudi Li, Leiyan Yang, Cheng Chen, Lupin Jiang, Qingchun Deng, Chenwen Li, Zhiqing Liang, Jianxiang Zhang
    Journal of Controlled Release.2023; 360: 496.     CrossRef
  • Viral manipulation of cell polarity signalling
    Airah Javorsky, Patrick O. Humbert, Marc Kvansakul
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2023; 1870(7): 119536.     CrossRef
  • The Undefinable Links: Unraveling the Mysterious Relationships Between Viruses and the Human
    Yuening Li
    Highlights in Science, Engineering and Technology.2023; 54: 397.     CrossRef
  • Herpes Simplex Virus, Human Papillomavirus, and Cervical Cancer: Overview, Relationship, and Treatment Implications
    Daniel Sausen, Oren Shechter, Elisa Gallo, Harel Dahari, Ronen Borenstein
    Cancers.2023; 15(14): 3692.     CrossRef
  • The potential role of the microbiota in prostate cancer pathogenesis and treatment
    Nicolò Pernigoni, Christina Guo, Lewis Gallagher, Wei Yuan, Manuel Colucci, Martina Troiani, Lei Liu, Luisa Maraccani, Ilaria Guccini, Denis Migliorini, Johann de Bono, Andrea Alimonti
    Nature Reviews Urology.2023; 20(12): 706.     CrossRef
  • Clinicopathologic and Molecular Characterization of Anorectal Neuroendocrine Carcinomas Reveals Human Papillomavirus, p53, and c-Myc as Alternative Mechanisms of Carcinogenesis
    Allison J. Cox, William E. Crowe, Qi Yang, Bin Zhang, Zoltán N. Oltvai, Xiaoyan Liao
    Modern Pathology.2023; 36(11): 100295.     CrossRef
  • An updated systemic review and meta-analysis on human papillomavirus in breast carcinogenesis
    Usman Ayub Awan, Aamer Ali Khattak, Noman Ahmed, Xingyi Guo, Sohail Akhtar, Shehrish Kamran, Zhao Yongjing, Jianbo Liu, Suliman Khan
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Role of MLH1 and MSH2 deficiency in the development of tumorigenesis and chemo-tolerance of cervical Carcinoma: Clinical implications
    Priyanka Dutta, Debolina Pal, Anup Roy, Ranajit Kumar Mandal, Chinmay Kumar Panda
    Gene.2023; 888: 147746.     CrossRef
  • Detection of High-Grade Cervical Intraepithelial Neoplasia by Electrical Impedance Spectroscopy in Women Diagnosed with Low-Grade Cervical Intraepithelial Neoplasia in Cytology
    Georgios Panagakis, Ioannis K. Papapanagiotou, Charalampos Theofanakis, Paraskevi Tsetsa, Adamantia Kontogeorgi, Nikolaos Thomakos, Alexandros Rodolakis, Dimitrios Haidopoulos
    Life.2023; 13(11): 2139.     CrossRef
  • MULTİPL SKLEROZ HASTALARINDA SERVİKAL DİSPLAZİ RİSKİ
    Özlem Kayacık Günday, Gökçe Zeytin Demiral, Şerafettin Baysal, Tacettin Sevim, Selin Yoldaş, Berkay Çelebi, Ensar Çam
    Kocatepe Tıp Dergisi.2023; 24(4): 493.     CrossRef
  • p16/Ki67 dual stain triage versus cytology in primary human papillomavirus‐based cervical cancer screening with limited genotyping
    Martyna Trzeszcz, Maciej Mazurec, Robert Jach, Karolina Mazurec, Izabela Kotkowska‐Szeps, Magdalena Kania, Mariola Wantuchowicz, Jolanta Wasowska, Monika Duczek‐Polakiewicz, Patrycja Rozmus, Joanna Streb, Agnieszka Halon
    Journal of Medical Virology.2023;[Epub]     CrossRef
  • From Diagnosis to Treatment: Exploring the Latest Management Trends in Cervical Intraepithelial Neoplasia
    Saloni Gupta, Nikhilesh Nagtode, Vaibhav Chandra, Kavita Gomase
    Cureus.2023;[Epub]     CrossRef
  • Regulatory Effect of Ficus carica Latex on Cell Cycle Progression in Human Papillomavirus-Positive Cervical Cancer Cell Lines: Insights from Gene Expression Analysis
    Muharrem Cakir, Ugur Bilge, Arshia Ghanbari, G. Ashrafi
    Pharmaceuticals.2023; 16(12): 1723.     CrossRef
  • Leveraging innovative therapies with an evolving understanding of the molecular pathogenesis of penile squamous cell carcinoma
    Ali Hajiran, Taylor Bracco, Logan Zemp, Philippe E. Spiess
    Urologic Oncology: Seminars and Original Investigations.2022; 40(5): 173.     CrossRef
  • Antioxidant and Cytotoxic Activities of Exopolysaccharides from Alcaligenes faecalis Species Isolated from the Marine Environment of Mauritius
    Aadil Ahmad Aullybux, Daneshwar Puchooa, Theeshan Bahorun, Rajesh Jeewon, Xuesong Wen, Poona Matin
    Journal of Polymers and the Environment.2022; 30(4): 1462.     CrossRef
  • Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinoma
    Abeer M. Salama, Amir Momeni-Boroujeni, Chad Vanderbilt, Marc Ladanyi, Robert Soslow
    Modern Pathology.2022; 35(2): 274.     CrossRef
  • Haemophilus pittmaniae and Leptotrichia spp. Constitute a Multi-Marker Signature in a Cohort of Human Papillomavirus-Positive Head and Neck Cancer Patients
    Jean-Luc C. Mougeot, Micaela F. Beckman, Holden C. Langdon, Rajesh V. Lalla, Michael T. Brennan, Farah K. Bahrani Mougeot
    Frontiers in Microbiology.2022;[Epub]     CrossRef
  • Therapeutic DNA Vaccines against HPV-Related Malignancies: Promising Leads from Clinical Trials
    Jianming Tang, Mingzhu Li, Chao Zhao, Danhua Shen, Lei Liu, Xiujun Zhang, Lihui Wei
    Viruses.2022; 14(2): 239.     CrossRef
  • Modelling Chlamydia and HPV co-infection in patient-derived ectocervix organoids reveals distinct cellular reprogramming
    Stefanie Koster, Rajendra Kumar Gurumurthy, Naveen Kumar, Pon Ganish Prakash, Jayabhuvaneshwari Dhanraj, Sofia Bayer, Hilmar Berger, Shilpa Mary Kurian, Marina Drabkina, Hans-Joachim Mollenkopf, Christian Goosmann, Volker Brinkmann, Zachary Nagel, Mandy M
    Nature Communications.2022;[Epub]     CrossRef
  • Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances
    Jiahui Zhang, Jingyi Fan, Mariusz Skwarczynski, Rachel J Stephenson, Istvan Toth, Waleed M Hussein
    International Journal of Nanomedicine.2022; Volume 17: 869.     CrossRef
  • Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
    Paul Shafer, Lauren M. Kelly, Valentina Hoyos
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Human Papillomavirus E6/E7 oncogene transcripts as biomarkers for the early detection of cervical cancer
    Sadhana M Gupta, Himangi Warke, Hemangi Chaudhari, Padmaja Mavani, Rajshree D. Katke, Shilpa C. Kerkar, Jayanti Mania‐Pramanik
    Journal of Medical Virology.2022; 94(7): 3368.     CrossRef
  • Targeting metabolism: A potential strategy for hematological cancer therapy
    Xue Tang, Fen Chen, Li-Chun Xie, Si-Xi Liu, Hui-Rong Mai
    World Journal of Clinical Cases.2022; 10(10): 2990.     CrossRef
  • Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia
    Tafadzwa Chihanga, Sara Vicente-Muñoz, Sonya Ruiz-Torres, Bidisha Pal, Mathieu Sertorio, Paul R. Andreassen, Ruby Khoury, Parinda Mehta, Stella M. Davies, Andrew N. Lane, Lindsey E. Romick-Rosendale, Susanne I. Wells
    Cancers.2022; 14(8): 2040.     CrossRef
  • Current and future direction in treatment of HPV-related cervical disease
    Niloofar Khairkhah, Azam Bolhassani, Reza Najafipour
    Journal of Molecular Medicine.2022; 100(6): 829.     CrossRef
  • Parent Attitudes regarding Orthodontists’ Role as Potential Administrators of Human Papilloma Virus (HPV) Vaccines
    Gloria Lee, Jessica Begley, Kavita Ahluwalia, Jaffer A Shariff, Sunil Wadhwa, Christine O’Hea, Gaetano Isola
    International Journal of Dentistry.2022; 2022: 1.     CrossRef
  • Graphene Quantum Dots – Hydrothermal Green Synthesis, Material Characterization and Prospects for Cervical Cancer Diagnosis Applications: A Review
    Raghavv Raghavender Suresh, Arockia Jayalatha Kulandaisamy, Noel Nesakumar, Saisubramanian Nagarajan, Jung Heon Lee, John Bosco Balaguru Rayappan
    ChemistrySelect.2022;[Epub]     CrossRef
  • Interplay between cellular metabolism and DNA viruses
    Milad Zandi, Somayeh Shokri, Shahab Mahmoudvand, Ahmad Hosseinzadeh Adli, Ramin Mohammadi, Azita Haddadi
    Journal of Medical Virology.2022; 94(11): 5163.     CrossRef
  • Breast Cancer Risk and Human Papillomavirus Infection: A Bradford Hill Criteria Based Evaluation
    Muhammad Usman, Yasir Hameed, Mukhtiar Ahmad, Jalil Ur Rehman, Hamad Ahmed, Muhammad Safdar Hussain, Rizwan Asif, Muhammad Ghulam Murtaza, Muhammad Tayyab Jawad, Muhammad Junaid Iqbal
    Infectious Disorders - Drug Targets.2022;[Epub]     CrossRef
  • Sensor detection in gynaecological medicine
    Michael Thompson, Soha Ahmadi, Katharina Davoudian, Brian De La Franier, Navina Lotay, Marcus Q. Bernardini
    Sensors & Diagnostics.2022; 1(5): 877.     CrossRef
  • Cervical cancer screening, treatment and prophylaxis in Brazil: Current and future perspectives for cervical cancer elimination
    Flávia M. Corrêa, Arn Migowski, Liz M. de Almeida, Marcelo A. Soares
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • HPV-mediated Cervical Cancer: A Systematic Review on Immunological Basis, Molecular Biology, and Immune Evasion Mechanisms
    Ramar Vanajothi, Natarajan Srikanth, Rajendran Vijayakumar, Manikandan Palanisamy, Sundaresan Bhavaniramya, Kumpati Premkumar
    Current Drug Targets.2022; 23(8): 782.     CrossRef
  • Potential role of human papillomavirus proteins associated with the development of cancer
    Dhanvee Balaji, Iyshwarya Bhaskar Kalarani, Vajagathali Mohammed, Ramakrishnan Veerabathiran
    VirusDisease.2022; 33(3): 322.     CrossRef
  • Proton-induced DNA damage promotes integration of foreign plasmid DNA into human genome
    Meghri Katerji, Antonella Bertucci, Valery Filippov, Marcelo Vazquez, Xin Chen, Penelope J. Duerksen-Hughes
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Anti-cancer properties of Caulerpa racemosa by altering expression of Bcl-2, BAX, cleaved caspase 3 and apoptosis in HeLa cancer cell culture
    Happy Kurnia Permatasari, Defny Silvia Wewengkang, Nur Iedha Tertiana, Farida Zharfani Muslim, Muhammad Yusuf, Shintya Octaviana Baliulina, Vanessa Pradna Adyana Daud, Aurielle Annalicia Setiawan, Fahrul Nurkolis
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Does Lactobacillus Exert a Protective Effect on the Development of Cervical and Endometrial Cancer in Women?
    Karolina Frąszczak, Bartłomiej Barczyński, Adrianna Kondracka
    Cancers.2022; 14(19): 4909.     CrossRef
  • Cervical cancer screening: Past, present and outlook
    Radomir Živadinović, Aleksandra Petrić, Aleksandar Živadinović, Sonja Pop-Trajković, Lazar Živadinović, Dušan Simić
    Glasnik javnog zdravlja.2022; 96(3): 333.     CrossRef
  • HPV-18 E7 Interacts with Elk-1 Leading to Elevation of the Transcriptional Activity of Elk-1 in Cervical Cancer
    Sung-Ho Go, Seung Bae Rho, Dong-Wha Yang, Boh-Ram Kim, Chang Hoon Lee, Seung-Hoon Lee
    Biomolecules & Therapeutics.2022; 30(6): 593.     CrossRef
  • A Reverse Structure-based Design of HPV E7 Inhibitor
    Wan Chein Tan, Shatrah Othman, See Khai Lim, Nurshamimi Nor Rashid, Choon Han Heh
    Current Computer-Aided Drug Design.2022; 18(4): 318.     CrossRef
  • Investigation of Curcumin-Loaded OA400 Nanoparticle’s Effect on the Expression of E6 and E7 Human Papilloma-Virus Oncogenes and P53 and Rb Factors in HeLa Cell Line
    Rezvaneh Vahedian Sadeghi, Masoud Parsania, Majid Sadeghizadeh, Setareh Haghighat
    Iranian Journal of Pharmaceutical Research.2022;[Epub]     CrossRef
  • Enhancing the Effect of Nucleic Acid Vaccines in the Treatment of HPV-Related Cancers: An Overview of Delivery Systems
    Ingrid Andrêssa de Moura, Anna Jéssica Duarte Silva, Larissa Silva de Macêdo, Maria da Conceição Viana Invenção, Mylenna Máyra Gois de Sousa, Antonio Carlos de Freitas
    Pathogens.2022; 11(12): 1444.     CrossRef
  • Effects of Human Papilloma Virus E6/E7 Oncoproteins on Genomic Structure in Head and Neck Squamous Cell Carcinoma
    Matthew Uzelac, Armon Barakchi, Varsha Beldona, Daniel John, Jaideep Chakladar, Wei Tse Li, Weg M. Ongkeko
    Cancers.2022; 14(24): 6190.     CrossRef
  • Towards Novel Gene and Cell Therapy Approaches for Cervical Cancer
    Robert Polten, Ivana Kutle, Jens Hachenberg, Rüdiger Klapdor, Michael Morgan, Axel Schambach
    Cancers.2022; 15(1): 263.     CrossRef
  • The Presence of Human Papillomavirus and Epstein-Barr Virus Infection in Gastric Cancer: A Systematic Study
    Abolfazl Jafari-Sales, Afsoon Shariat, Hossein Bannazadeh Baghi, Behzad Baradaran, Behboud Jafari
    Oncologie.2022; 24(3): 413.     CrossRef
  • Immunology of HPV-mediated cervical cancer: current understanding
    Babban Jee, Renu Yadav, Sangeeta Pankaj, Shivendra Kumar Shahi
    International Reviews of Immunology.2021; 40(5): 359.     CrossRef
  • The role of human papillomavirus in the pathogenesis of sinonasal inverted papilloma: a narrative review
    Rohit Gupta, Peter L. Rady, Andrew G. Sikora, Stephen K. Tyring
    Reviews in Medical Virology.2021;[Epub]     CrossRef
  • The role of HPV gene expression and selected cellular MiRNAs in lung cancer development
    Bashdar Mahmud Hussen, Gelavizh Ahmadi, Havva Marzban, Maryam Ebadi Fard Azar, Saba Sorayyayi, Romina Karampour, Javid Sadri Nahand, Hazha Jamal Hidayat, Mohsen Moghoofei
    Microbial Pathogenesis.2021; 150: 104692.     CrossRef
  • Adjunctive testing by cytology, p16/Ki‐67 dual‐stained cytology or HPV16/18 E6 oncoprotein for the management of HPV16/18 screen‐positive women
    Leticia Torres‐Ibarra, Attila T. Lorincz, Cosette M. Wheeler, Jack Cuzick, Rubí Hernández‐López, Donna Spiegelman, Leith León‐Maldonado, Berenice Rivera‐Paredez, Pablo Méndez‐Hernández, Eduardo Lazcano‐Ponce, Jorge Salmerón
    International Journal of Cancer.2021; 148(9): 2264.     CrossRef
  • EGFR Protein Expression Relates with Tumor Histology, Methylation Status of EGFR and HPV16 E6 Viral Load in Oropharyngeal Carcinoma
    Yo Suzuki, Yuki Fukumura, Miki Asahina, Mitsuhisa Fujimaki, Shinichi Ohba, Fumihiko Matsumoto, Isao Kurahayashi, Takashi Yao, Katsuhisa Ikeda
    Head and Neck Pathology.2021; 15(3): 743.     CrossRef
  • An internal class III PDZ binding motif in HPV16 E6* protein is required for Dlg degradation activity
    Wareerat Umnajvijit, Jariya Sangthong, Fabien Loison, Kulthida Vaeteewoottacharn, Mathurose Ponglikitmongkol
    Biochimica et Biophysica Acta (BBA) - General Subjects.2021; 1865(5): 129850.     CrossRef
  • Microbiota Effects on Carcinogenesis: Initiation, Promotion, and Progression
    Lacey R. Lopez, Rachel M. Bleich, Janelle C. Arthur
    Annual Review of Medicine.2021; 72(1): 243.     CrossRef
  • Ovulatory Follicular Fluid Facilitates the Full Transformation Process for the Development of High-Grade Serous Carcinoma
    Che-Fang Hsu, Pao-Chu Chen, Vaishnavi Seenan, Dah-Ching Ding, Tang-Yuan Chu
    Cancers.2021; 13(3): 468.     CrossRef
  • Is There a Carcinogenic Risk Attached to Vitamin B12 Deficient Diets and What Should We Do About It? Reviewing the Facts
    Alexandra K. Loedin, Dave Speijer
    Molecular Nutrition & Food Research.2021;[Epub]     CrossRef
  • Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
    Saghi Nooraei, Howra Bahrulolum, Zakieh Sadat Hoseini, Camellia Katalani, Abbas Hajizade, Andrew J. Easton, Gholamreza Ahmadian
    Journal of Nanobiotechnology.2021;[Epub]     CrossRef
  • Focus on HPV Infection and the Molecular Mechanisms of Oral Carcinogenesis
    Luigi Santacroce, Michele Di Cosola, Lucrezia Bottalico, Skender Topi, Ioannis Alexandros Charitos, Andrea Ballini, Francesco Inchingolo, Angela Pia Cazzolla, Gianna Dipalma
    Viruses.2021; 13(4): 559.     CrossRef
  • An Emerging Anti-p16 Antibody-BC42 Clone as an Alternative to the Current E6H4 for Use in the Female Genital Tract Pathological Diagnosis: Our Experience and a Review on p16ink4a Functional Significance, Role in Daily-Practice Diagnosis, Prognostic Potent
    Giuseppe Angelico, Angela Santoro, Frediano Inzani, Patrizia Straccia, Saveria Spadola, Damiano Arciuolo, Michele Valente, Nicoletta D’Alessandris, Roberta Benvenuto, Antonio Travaglino, Antonio Raffone, Gian Franco Zannoni
    Diagnostics.2021; 11(4): 713.     CrossRef
  • Dynamic crosstalk within the tumor microenvironment of uterine cervical carcinoma: baseline network, iatrogenic alterations, and translational implications
    Rosalba De Nola, Vera Loizzi, Ettore Cicinelli, Gennaro Cormio
    Critical Reviews in Oncology/Hematology.2021; 162: 103343.     CrossRef
  • Meet the Insidious Players: Review of Viral Infections in Head and Neck Cancer Etiology with an Update on Clinical Trials
    Lejla Mahmutović, Esma Bilajac, Altijana Hromić-Jahjefendić
    Microorganisms.2021; 9(5): 1001.     CrossRef
  • Degradation of p53 by HPV16-E6 variants isolated from cervical cancer specimens of Moroccan women
    Khaoula HADAMI, Charles SABY, Nadia DAKKA, Guillaume COLLIN, Mohammed ATTALEB, Meriem KHYATTI, Abdelkarim FILALI-MALTOUF, Hamid MORJANI, Mohammed EL MZIBRI
    Gene.2021; 791: 145709.     CrossRef
  • The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy
    Sylvia Annabel Dass, Rehasri Selva Rajan, Gee Jun Tye, Venugopal Balakrishnan
    Human Vaccines & Immunotherapeutics.2021; 17(9): 2981.     CrossRef
  • UVB Inhibits Proliferation, Cell Cycle and Induces Apoptosis via p53, E2F1 and Microtubules System in Cervical Cancer Cell Lines
    Angelica Judith Granados-López, Eduardo Manzanares-Acuña, Yamilé López-Hernández, Julio Enrique Castañeda-Delgado, Ixamail Fraire-Soto, Claudia Araceli Reyes-Estrada, Rosalinda Gutiérrez-Hernández, Jesús Adrián López
    International Journal of Molecular Sciences.2021; 22(10): 5197.     CrossRef
  • Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation of Cervical Cancer Cells
    Jinshun Zhu, Saidu Kamara, Qi Wang, Yanru Guo, Qingfeng Li, Linlin Wang, Jingjing Chen, Qianqian Du, Wangqi Du, Shao Chen, Shanli Zhu, Jun Chen, Maoping Chu, Lifang Zhang
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • Recent Progress in Electrochemical Detection of Human Papillomavirus (HPV) via Graphene‐Based Nanosensors
    Seyyed Mojtaba Mousavi, Gity Behbudi, Seyyed Alireza Hashemi, Aziz Babapoor, Wei-Hung Chiang, Seeram Ramakrishna, Mohammed Muzibur Rahman, Chin Wei Lai, Ahmad Gholami, Navid Omidifar, Khadije Yousefi, Bruno C. Janegitz
    Journal of Sensors.2021;[Epub]     CrossRef
  • Antioxidants Associated With Oncogenic Human Papillomavirus Infection in Women
    Hui-Yi Lin, Qiufan Fu, Yu-Hsiang Kao, Tung-sung Tseng, Krzysztof Reiss, Jennifer E Cameron, Martin J Ronis, Joseph Su, Navya Nair, Hsiao-Man Chang, Michael E Hagensee
    The Journal of Infectious Diseases.2021; 224(9): 1520.     CrossRef
  • The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities
    Laura M. Chambers, Parker Bussies, Roberto Vargas, Emily Esakov, Surabhi Tewari, Ofer Reizes, Chad Michener
    Current Oncology Reports.2021;[Epub]     CrossRef
  • Interpretations on the Interaction between Protein Tyrosine Phosphatase and E7 Oncoproteins of High and Low-Risk HPV: A Computational Perception
    Murali Aarthy, Sanjeev Kumar Singh
    ACS Omega.2021; 6(25): 16472.     CrossRef
  • Validation of Potential Protein Markers Predicting Chemoradioresistance in Early Cervical Cancer by Immunohistochemistry
    Soo Young Jeong, Joon-Yong Chung, Sun-Ju Byeon, Chul Jung Kim, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Ye Lin Chae, So Young Oh, Chel Hun Choi
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Viral load and interaction of HPV oncoprotein E6 and E7 with host cellular markers in the progression of cervical cancer
    Bilal Ahmad Mir, P. F. Rahaman, Arif Ahmad
    AIMS Molecular Science.2021; 8(3): 184.     CrossRef
  • Integrin alpha 6 as a stemness driver is a novel promising target for HPV (+) head and neck squamous cell carcinoma
    Jin Seol An, Jung Hwa Moon, Chayeon Kim, Joo Kyung No, Young Gyu Eun, Young Chang Lim
    Experimental Cell Research.2021; 407(2): 112815.     CrossRef
  • Reduced MAGI3 level by HPV18E6 contributes to Wnt/β‐catenin signaling activation and cervical cancer progression
    Zhuoli Yang, Hua Liu, Ran Song, Wenxiu Lu, Haibo Wang, Siyu Gu, Xuedi Cao, Yibin Chen, Jihuan Liang, Qiong Qin, Xiaomei Yang, Duiping Feng, Junqi He
    FEBS Open Bio.2021; 11(11): 3051.     CrossRef
  • An Integrated View of Virus-Triggered Cellular Plasticity Using Boolean Networks
    Jenny Paola Alfaro-García, María Camila Granados-Alzate, Miguel Vicente-Manzanares, Juan Carlos Gallego-Gómez
    Cells.2021; 10(11): 2863.     CrossRef
  • Role of interleukin-17 in human papillomavirus infection and associated malignancies
    Utkarsha Sahu, Prashant Khare
    Microbial Pathogenesis.2021; 161: 105294.     CrossRef
  • FNDC3B and BPGM Are Involved in Human Papillomavirus-Mediated Carcinogenesis of Cervical Cancer
    Luhan Zhang, Hong Yu, Tian Deng, Li Ling, Juan Wen, Mingfen Lv, Rongying Ou, Qiaozhi Wang, Yunsheng Xu
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Investigating host-virus interaction mechanism and phylogenetic analysis of viral proteins involved in the pathogenesis
    Ahmad Abu Turab Naqvi, Farah Anjum, Alaa Shafie, Sufian Badar, Abdelbaset Mohamed Elasbali, Dharmendra Kumar Yadav, Md. Imtaiyaz Hassan, Timir Tripathi
    PLOS ONE.2021; 16(12): e0261497.     CrossRef
  • Potential anticancer effect of aspirin and 2'‑hydroxy‑2,3,5'‑trimethoxychalcone‑linked polymeric micelles against cervical cancer through apoptosis
    Kang Lee, Suji Baek, Myeong Yoon, Ji Park, Bok Hong, Sang Lee, Seung Oh, Seung Kwon, Ruda Lee, Dae Lee, Kang-Seo Park, Byung Moon
    Oncology Letters.2021;[Epub]     CrossRef
  • HPVE6-USP46 Mediated Cdt2 Stabilization Reduces Set8 Mediated H4K20-Methylation to Induce Gene Expression Changes
    Shashi Kiran, Briana Wilson, Shekhar Saha, Julia Ann Graff, Anindya Dutta
    Cancers.2021; 14(1): 30.     CrossRef
  • Translatable gene therapy for lung cancer using Crispr CAS9—an exploratory review
    Jishnu Nair, Abhishek Nair, Soundaram Veerappan, Dwaipayan Sen
    Cancer Gene Therapy.2020; 27(3-4): 116.     CrossRef
  • Cancer signaling by plasmonic quantum probes
    Ayushi Agarwal, Krishnan Venkatakrishnan, Bo Tan
    Applied Materials Today.2020; 18: 100465.     CrossRef
  • Multistate Markov Model to Predict the Prognosis of High-Risk Human Papillomavirus-Related Cervical Lesions
    Ayumi Taguchi, Konan Hara, Jun Tomio, Kei Kawana, Tomoki Tanaka, Satoshi Baba, Akira Kawata, Satoko Eguchi, Tetsushi Tsuruga, Mayuyo Mori, Katsuyuki Adachi, Takeshi Nagamatsu, Katsutoshi Oda, Toshiharu Yasugi, Yutaka Osuga, Tomoyuki Fujii
    Cancers.2020; 12(2): 270.     CrossRef
  • Early-stage cervical cancer diagnosis based on an ultra-sensitive electrochemical DNA nanobiosensor for HPV-18 detection in real samples
    Pegah Mahmoodi, Majid Rezayi, Elisa Rasouli, Amir Avan, Mehrdad Gholami, Majid Ghayour Mobarhan, Ehsan Karimi, Yatima Alias
    Journal of Nanobiotechnology.2020;[Epub]     CrossRef
  • Cervical Cancer Screening: Past, Present, and Future
    Sarah L. Bedell, Lena S. Goldstein, Amelia R. Goldstein, Andrew T. Goldstein
    Sexual Medicine Reviews.2020; 8(1): 28.     CrossRef
  • Potential oncogenic roles of mutant-p53-derived exosomes in the tumor–host interaction of head and neck cancers
    Etti Ester Azulay, Tomer Cooks, Moshe Elkabets
    Cancer Immunology, Immunotherapy.2020; 69(2): 285.     CrossRef
  • Extracellular Vesicles from Human Papilloma Virus-Infected Cervical Cancer Cells Enhance HIV-1 Replication in Differentiated U1 Cell Line
    Sabina Ranjit, Sunitha Kodidela, Namita Sinha, Subhash Chauhan, Santosh Kumar
    Viruses.2020; 12(2): 239.     CrossRef
  • Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies
    Renjian Hu, Zhen Dong, Kui Zhang, Guangzhao Pan, Chongyang Li, Hongjuan Cui
    Viruses.2020; 12(3): 333.     CrossRef
  • Cell Cycle Profiling Reveals Protein Oscillation, Phosphorylation, and Localization Dynamics
    Patrick Herr, Johan Boström, Eric Rullman, Sean G. Rudd, Mattias Vesterlund, Janne Lehtiö, Thomas Helleday, Gianluca Maddalo, Mikael Altun
    Molecular & Cellular Proteomics.2020; 19(4): 608.     CrossRef
  • HPV Infection Significantly Accelerates Glycogen Metabolism in Cervical Cells with Large Nuclei: Raman Microscopic Study with Subcellular Resolution
    Katarzyna Sitarz, Krzysztof Czamara, Joanna Bialecka, Malgorzata Klimek, Barbara Zawilinska, Slawa Szostek, Agnieszka Kaczor
    International Journal of Molecular Sciences.2020; 21(8): 2667.     CrossRef
  • Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
    Shaian Tavakolian, Hossein Goudarzi, Ebrahim Faghihloo
    Infectious Agents and Cancer.2020;[Epub]     CrossRef
  • Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment
    Mohsen Keshavarz, Mir Saeed Ebrahimzadeh, Seyed Mohammad Miri, Hassan Dianat-Moghadam, Seyedeh Sara Ghorbanhosseini, Seyed Reza Mohebbi, Hossein Keyvani, Amir Ghaemi
    Virology Journal.2020;[Epub]     CrossRef
  • Virus-Specific T Cells for the Treatment of Malignancies—Then, Now, and the Future
    Sandhya Sharma, Wingchi K Leung, Helen E Heslop
    Current Stem Cell Reports.2020; 6(2): 17.     CrossRef
  • The Relationship between Estrogen-Related Signaling and Human Papillomavirus Positive Cancers
    Claire D. James, Iain M. Morgan, Molly L. Bristol
    Pathogens.2020; 9(5): 403.     CrossRef
  • Combination Vaccination With Tetanus Toxoid and Enhanced Tumor-Cell Based Vaccine Against Cervical Cancer in a Mouse Model
    Donia Alson, Scott C. Schuyler, Bo-Xin Yan, Karthika Samimuthu, Jiantai Timothy Qiu
    Frontiers in Immunology.2020;[Epub]     CrossRef
  • HPV‐related methylation‐based reclassification and risk stratification of cervical cancer
    Si Yang, Ying Wu, Shuqian Wang, Peng Xu, Yujiao Deng, Meng Wang, Kang Liu, Tian Tian, Yuyao Zhu, Na Li, Linghui Zhou, Zhijun Dai, Huafeng Kang
    Molecular Oncology.2020; 14(9): 2124.     CrossRef
  • Anti-tumor activities of probiotics in cervical cancer
    Moghaddaseh Jahanshahi, Parisa Maleki Dana, Bita Badehnoosh, Zatollah Asemi, Jamal Hallajzadeh, Mohammad Ali Mansournia, Bahman Yousefi, Bahram Moazzami, Shahla Chaichian
    Journal of Ovarian Research.2020;[Epub]     CrossRef
  • Dysregulation of Stemness Pathways in HPV Mediated Cervical Malignant Transformation Identifies Potential Oncotherapy Targets
    Megha Budhwani, Samuel W. Lukowski, Sandro V. Porceddu, Ian H. Frazer, Janin Chandra
    Frontiers in Cellular and Infection Microbiology.2020;[Epub]     CrossRef
  • Bee venom inhibits the proliferation and migration of cervical-cancer cells in an HPV E6/E7-dependent manner
    Da-Hyun Kim, Hyun-Woo Lee, Hyun-Woo Park, Han-Woong Lee, Kyung-Hee Chun
    BMB Reports.2020; 53(8): 419.     CrossRef
  • The association between HPV gene expression, inflammatory agents and cellular genes involved in EMT in lung cancer tissue
    Marzieh Rezaei, Shayan Mostafaei, Amir Aghaei, Nayyerehalsadat Hosseini, Hassan Darabi, Majid Nouri, Ashkan Etemadi, Andrew O’. Neill, Javid Sadri Nahand, Hamed Mirzaei, Seamas C. Donnelly, Mohammad Doroudian, Mohsen Moghoofei
    BMC Cancer.2020;[Epub]     CrossRef
  • The role of viruses in adenocarcinoma development
    Mohsen Nakhaie, Javad Charostad, Gholam Abbas Kaydani, Ebrahim Faghihloo
    Infection, Genetics and Evolution.2020; 86: 104603.     CrossRef
  • Use of Cap Analysis Gene Expression to detect human papillomavirus promoter activity patterns at different disease stages
    Ayumi Taguchi, Kazunori Nagasaka, Charles Plessy, Hiroe Nakamura, Yoshiko Kawata, Sachi Kato, Kosuke Hashimoto, Takeshi Nagamatsu, Katsutoshi Oda, Iwao Kukimoto, Kei Kawana, Piero Carninci, Yutaka Osuga, Tomoyuki Fujii
    Scientific Reports.2020;[Epub]     CrossRef
  • Potential therapeutic and pharmacological effects of Wogonin: an updated review
    Do Luong Huynh, Tran Hoang Ngau, Nguyen Hoai Nguyen, Gia-Buu Tran, Cuong Thach Nguyen
    Molecular Biology Reports.2020; 47(12): 9779.     CrossRef
  • The Molecular and Pathophysiological Functions of Members of the LNX/PDZRN E3 Ubiquitin Ligase Family
    Jeongkwan Hong, Minho Won, Hyunju Ro
    Molecules.2020; 25(24): 5938.     CrossRef
  • Investigating the aetiology of adverse events following HPV vaccination with systems vaccinology
    Joan Campbell-Tofte, Aristidis Vrahatis, Knud Josefsen, Jesper Mehlsen, Kaj Winther
    Cellular and Molecular Life Sciences.2019; 76(1): 67.     CrossRef
  • DNA methyltransferases in virus‐associated cancers
    Javad Charostad, Akram Astani, Hossein Goudarzi, Ebrahim Faghihloo
    Reviews in Medical Virology.2019;[Epub]     CrossRef
  • Identification and characterization of an alternative cancer-derived PD-L1 splice variant
    Nadia B. Hassounah, Venkat S. Malladi, Yi Huang, Samuel S. Freeman, Ellen M. Beauchamp, Shohei Koyama, Nicholas Souders, Sunil Martin, Glenn Dranoff, Kwok-Kin Wong, Chandra S. Pedamallu, Peter S. Hammerman, Esra A. Akbay
    Cancer Immunology, Immunotherapy.2019; 68(3): 407.     CrossRef
  • What is the potential of p53 isoforms as a predictive biomarker in the treatment of cancer?
    Liam Hayman, Wajeeh Raza Chaudhry, Victor V. Revin, Nikolai Zhelev, Jean-Christophe Bourdon
    Expert Review of Molecular Diagnostics.2019; 19(2): 149.     CrossRef
  • Transforming properties of ovine papillomaviruses E6 and E7 oncogenes
    Gessica Tore, Gian Mario Dore, Carla Cacciotto, Rosita Accardi, Antonio G. Anfossi, Luisa Bogliolo, Marco Pittau, Salvatore Pirino, Tiziana Cubeddu, Massimo Tommasino, Alberto Alberti
    Veterinary Microbiology.2019; 230: 14.     CrossRef
  • Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins
    Niloofar Khodabandehlou, Shayan Mostafaei, Ashkan Etemadi, Amir Ghasemi, Mehrdad Payandeh, Shima Hadifar, Amir Hossein Norooznezhad, Anoshirvan Kazemnejad, Mohsen Moghoofei
    BMC Cancer.2019;[Epub]     CrossRef
  • HPVE6/E7,hTERT, andKi67mRNA RT-qPCR Assay for Detecting High-Grade Cervical Lesion with Microscope Slides
    Geehyuk Kim, Jemberu Taye, Kwangmin Yu, Sunyoung Park, Jungho Kim, Sunghyun Kim, Dongsup Lee, Hye-young Wang, Kwang Hwa Park, Hyeyoung Lee
    Analytical Cellular Pathology.2019; 2019: 1.     CrossRef
  • A high-risk papillomavirus 18 E7 affibody-enabled in vivo imaging and targeted therapy of cervical cancer
    Ledan Wang, Wangqi Du, Shanli Zhu, Pengfei Jiang, Lifang Zhang
    Applied Microbiology and Biotechnology.2019; 103(7): 3049.     CrossRef
  • HOXC6 promotes cervical cancer progression via regulation of Bcl‐2
    Yongsheng Wang, Cong Wang, Na Liu, Jun Hou, Wenjing Xiao, Hui Wang
    The FASEB Journal.2019; 33(3): 3901.     CrossRef
  • Meta‐analysis of the accuracy of p16 or p16/Ki‐67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology
    Eliana Peeters, Nicolas Wentzensen, Christine Bergeron, Marc Arbyn
    Cancer Cytopathology.2019; 127(3): 169.     CrossRef
  • Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells
    Jamie A. Barr, Karen E. Hayes, Tayvia Brownmiller, Abby D. Harold, Rajaganapathi Jagannathan, Paul R. Lockman, Saleem Khan, Ivan Martinez
    Scientific Reports.2019;[Epub]     CrossRef
  • Pongapin and Karanjin, furanoflavanoids of Pongamia pinnata, induce G2/M arrest and apoptosis in cervical cancer cells by differential reactive oxygen species modulation, DNA damage, and nuclear factor kappa‐light‐chain‐enhancer of activated B cell signal
    Rituparna Roy, Debolina Pal, Subhayan Sur, Suvra Mandal, Prosenjit Saha, Chinmay Kumar Panda
    Phytotherapy Research.2019; 33(4): 1084.     CrossRef
  • Effect of Multiple Vaccinations with Tumor Cell-Based Vaccine with Codon-Modified GM-CSF on Tumor Growth in a Mouse Model
    Jiantai Qiu, Donia Alson, Ta-Hsien Lee, Ching-Chou Tsai, Ting-Wei Yu, Yu-Sing Chen, Ya-Fang Cheng, Chu-Chi Lin, Scott Schuyler
    Cancers.2019; 11(3): 368.     CrossRef
  • Flax seed oil reduced tumor growth, modulated immune responses and decreased HPV E6 and E7 oncoprotein expression in a murine model of ectopic cervical cancer
    Rashmi Deshpande, Prerna Raina, Kavita Shinde, Prakash Mansara, Manjiri Karandikar, Ruchika Kaul-Ghanekar
    Prostaglandins & Other Lipid Mediators.2019; 143: 106332.     CrossRef
  • The free energy landscape of the oncogene protein E7 of human papillomavirus type 16 reveals a complex interplay between ordered and disordered regions
    Predrag Kukic, Giuseppe Mattia Lo Piccolo, Marcela O. Nogueira, Dmitri I. Svergun, Michele Vendruscolo, Isabella C. Felli, Roberta Pierattelli
    Scientific Reports.2019;[Epub]     CrossRef
  • Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome
    Xiaofan Lu, Liyun Jiang, Liya Zhang, Yue Zhu, Wenjun Hu, Jiashuo Wang, Xinjia Ruan, Zhengbao Xu, Xiaowei Meng, Jun Gao, Xiaoping Su, Fangrong Yan
    Neoplasia.2019; 21(6): 591.     CrossRef
  • How to Steer and Control ERK and the ERK Signaling Cascade Exemplified by Looking at Cardiac Insufficiency
    Tim Breitenbach, Kristina Lorenz, Thomas Dandekar
    International Journal of Molecular Sciences.2019; 20(9): 2179.     CrossRef
  • Dietary Polyphenols, Resveratrol and Pterostilbene Exhibit Antitumor Activity on an HPV E6-Positive Cervical Cancer Model: An in vitro and in vivo Analysis
    Kaushiki Chatterjee, Sumit Mukherjee, Jonathan Vanmanen, Probal Banerjee, Jimmie E. Fata
    Frontiers in Oncology.2019;[Epub]     CrossRef
  • Human papilloma virus DNA-biomarker analysis for cervical cancer: Signal enhancement by gold nanoparticle-coupled tetravalent streptavidin-biotin strategy
    Qingfeng Lv, Yongmei Wang, Cuijin Su, Thangavel Lakshmipriya, Subash C.B. Gopinath, Kannaiyan Pandian, Veeradasan Perumal, Ying Liu
    International Journal of Biological Macromolecules.2019; 134: 354.     CrossRef
  • RNA-seq analysis in equine papillomavirus type 2-positive carcinomas identifies affected pathways and potential cancer markers as well as viral gene expression and splicing events
    Anna Sophie Ramsauer, Jakub Kubacki, Claude Favrot, Mathias Ackermann, Cornel Fraefel, Kurt Tobler
    Journal of General Virology .2019; 100(6): 985.     CrossRef
  • Different expression of GSK3β and pS9GSK3β depending on phenotype of cervical cancer: possible association of GSK3β with squamous cell carcinoma and pS9GSK3β with adenocarcinoma
    Kwanghee Ahn, Sojung Kweon, Dae Woon Kim, Hojung Lee
    Obstetrics & Gynecology Science.2019; 62(3): 157.     CrossRef
  • Delivery of microRNAs by Extracellular Vesicles in Viral Infections: Could the News be Packaged?
    Fabio Seiti Yamada Yoshikawa, Franciane Mouradian Emidio Teixeira, Maria Notomi Sato, Luanda Mara da Silva Oliveira
    Cells.2019; 8(6): 611.     CrossRef
  • The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer
    Jiao Chen, Yan Deng, Liangfei Ao, Yi Song, Yan Xu, Chi Chiu Wang, Kwong Wai Choy, Kwok Hung Tony Chung, Quan Du, Yi Sui, Tao Yang, Jing Yang, Hu Li, Chang Zou, Tao Tang
    Cancer Letters.2019; 460: 75.     CrossRef
  • A unique insert in the genomes of high-risk human papillomaviruses with a predicted dual role in conferring oncogenic risk
    Noam Auslander, Yuri I. Wolf, Svetlana A. Shabalina, Eugene V. Koonin
    F1000Research.2019; 8: 1000.     CrossRef
  • Papillomavirus DNA not detected in canine lobular orbital adenoma and normal conjunctival tissue
    Elizabeth A. F. Schaefer, Shirley Chu, Jacqueline W. Pearce, Jeffrey N. Bryan, Brian K. Flesner
    BMC Veterinary Research.2019;[Epub]     CrossRef
  • Phenotype-based discovery of a HeLa-specific cytotoxic molecule that downregulates HPV-mediated signaling pathwaysviaoxidative damage
    Sanghee Lee, Wansang Cho, Sungyoul Hong, Sihyeong Yi, Heejun Kim, Soo Yeon Baek, Hankum Park, Jinjoo Jung, Young Kee Shin, Seung Bum Park
    Organic & Biomolecular Chemistry.2019; 17(31): 7388.     CrossRef
  • High Incidence of Human Papillomavirus Types 16 and 18 in Cervical Carcinoma Patients in a Tertiary Care Unit, Jabalpur, MP, India
    Shyamji Rawat, Sulekha Yadav, Pranjil Mandloi, Chinkal Panihar, P. V. Barde
    Indian Journal of Gynecologic Oncology.2019;[Epub]     CrossRef
  • Advances in technologies for cervical cancer detection in low-resource settings
    Kathryn A. Kundrod, Chelsey A. Smith, Brady Hunt, Richard A. Schwarz, Kathleen Schmeler, Rebecca Richards-Kortum
    Expert Review of Molecular Diagnostics.2019; 19(8): 695.     CrossRef
  • Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System
    Chenhao Zhou, Zewen Kelvin Tuong, Ian Hector Frazer
    Frontiers in Oncology.2019;[Epub]     CrossRef
  • Identification of potential binding pocket on viral oncoprotein HPV16 E6: a promising anti-cancer target for small molecule drug discovery
    Srikanth Kolluru, Rosemary Momoh, Lydia Lin, Jayapal Reddy Mallareddy, John L. Krstenansky
    BMC Molecular and Cell Biology.2019;[Epub]     CrossRef
  • The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1
    Jennifer L. McCann, Madeline M. Klein, Evelyn M. Leland, Emily K. Law, William L. Brown, Daniel J. Salamango, Reuben S. Harris
    Journal of Biological Chemistry.2019; 294(32): 12099.     CrossRef
  • LncRNA SRA1 is down-regulated in HPV-negative cervical squamous cell carcinoma and regulates cancer cell behaviors
    Yunyong Liu, Mengdan Li, Huihui Yu, Haozhe Piao
    Bioscience Reports.2019;[Epub]     CrossRef
  • Diagnosis and management of vulvar cancer: A review
    Andrea Tan, Amy K. Bieber, Jennifer A. Stein, Miriam K. Pomeranz
    Journal of the American Academy of Dermatology.2019; 81(6): 1387.     CrossRef
  • Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter
    Nobumaru Hirao, Takashi Iwata, Kohsei Tanaka, Hiroshi Nishio, Masaru Nakamura, Tohru Morisada, Kenji Morii, Natsuki Maruyama, Yuki Katoh, Tomonori Yaguchi, Shigeki Ohta, Iwao Kukimoto, Daisuke Aoki, Yutaka Kawakami
    Gynecologic Oncology.2019; 155(2): 340.     CrossRef
  • Phase 1 Safety and Immunogenicity Trial of Recombinant Lactococcus lactis Expressing Human Papillomavirus Type 16 E6 Oncoprotein Vaccine
    Sedigheh Taghinezhad-S, Amir Hossein Mohseni, Hossein Keyvani, Mohammad Reza Razavi
    Molecular Therapy - Methods & Clinical Development.2019; 15: 40.     CrossRef
  • Cloning and expression of the L1 immunogenic protein of human papillomavirus genotype 16 by using Lactobacillus expression system
    Masumeh Haj Hodaei, Rudabeh Behzadi Anduhjerdi, Jalil Fallah Mehrabadi, Davoud Esmaeili
    Gene Reports.2019; 17: 100521.     CrossRef
  • Relationship between p16 expression and prognosis in different anatomic subsites of OSCC
    Yanhong Ni, Xiaoxin Zhang, Yunxia Wan, Kai Dun Tang, Yin Xiao, Yue Jing, Yuxian Song, Xiaofeng Huang, Chamindie Punyadeera, Qingang Hu
    Cancer Biomarkers.2019; 26(3): 375.     CrossRef
  • A unique insert in the genomes of high-risk human papillomaviruses with a predicted dual role in conferring oncogenic risk
    Noam Auslander, Yuri I. Wolf, Svetlana A. Shabalina, Eugene V. Koonin
    F1000Research.2019; 8: 1000.     CrossRef
  • A Current Update on Human Papillomavirus-Associated Head and Neck Cancers
    Ebenezer Tumban
    Viruses.2019; 11(10): 922.     CrossRef
  • Current Perspectives in Human Papilloma Virus: Where We are and What We Need?
    B.S Anjali Devi, Venugopal Reddy Bovilla, SubbaRao V. Madhunapantula
    Biomedical and Pharmacology Journal.2019; 12(04): 1683.     CrossRef
  • Plant viral and bacteriophage delivery of nucleic acid therapeutics
    Patricia Lam, Nicole F. Steinmetz
    WIREs Nanomedicine and Nanobiotechnology.2018;[Epub]     CrossRef
  • Prevalence of human papillomavirus in benign and malignant laryngeal lesions in Egyptian patients: Cross‐sectional study
    P. Milad, H. Kassamy, A. Askoura, S. Abuelela, R. Salem, D. Ragab
    Clinical Otolaryngology.2018; 43(1): 312.     CrossRef
  • Human papillomavirus E7 induces p63 expression to modulate DNA damage response
    Sahar Eldakhakhny, Qing Zhou, Emma J. Crosbie, Berna S. Sayan
    Cell Death & Disease.2018;[Epub]     CrossRef
  • ViFi: accurate detection of viral integration and mRNA fusion reveals indiscriminate and unregulated transcription in proximal genomic regions in cervical cancer
    Nam-phuong D Nguyen, Viraj Deshpande, Jens Luebeck, Paul S Mischel, Vineet Bafna
    Nucleic Acids Research.2018; 46(7): 3309.     CrossRef
  • Resveratrol and Pterostilbene Exhibit Anticancer Properties Involving the Downregulation of HPV Oncoprotein E6 in Cervical Cancer Cells
    Kaushiki Chatterjee, Dina AlSharif, Christina Mazza, Palwasha Syar, Mohamed Al Sharif, Jimmie E. Fata
    Nutrients.2018; 10(2): 243.     CrossRef
  • Use of protein-based biomarkers of exfoliated cervical cells for primary screening of cervical cancer
    Yingji Jin, Seung Cheol Kim, Hyoung Jin Kim, Woong Ju, Yun Hwan Kim, Hong-Jin Kim
    Archives of Pharmacal Research.2018; 41(4): 438.     CrossRef
  • ARFHPV E7 oncogene, lncRNA HOTAIR, miR‐331‐3p and its target, NRP2, form a negative feedback loop to regulate the apoptosis in the tumorigenesis in HPV positive cervical cancer
    Min Zhang, Yinghui Song, Furui Zhai
    Journal of Cellular Biochemistry.2018; 119(6): 4397.     CrossRef
  • Lupeol induces S-phase arrest and mitochondria-mediated apoptosis in cervical cancer cells
    Nupoor Prasad, Akash Sabarwal, Umesh C S Yadav, Rana P Singh
    Journal of Biosciences.2018; 43(2): 249.     CrossRef
  • Deregulated TNF-Alpha Levels Along with HPV Genotype 16 Infection Are Associated with Pathogenesis of Cervical Neoplasia in Northeast Indian Patients
    Chandana Ray Das, Diptika Tiwari, Anita Dongre, Mohammad Aasif Khan, Syed Akhtar Husain, Anirudha Sarma, Sujoy Bose, Purabi Deka Bose
    Viral Immunology.2018; 31(4): 282.     CrossRef
  • Lactobacillus Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens
    Jonathan S. LeCureux, Gregg A. Dean, Christopher J. Papasian
    mSphere.2018;[Epub]     CrossRef
  • SALL2 represses cyclins D1 and E1 expression and restrains G1/S cell cycle transition and cancer‐related phenotypes
    Viviana E. Hermosilla, Ginessa Salgado, Elizabeth Riffo, David Escobar, Matías I. Hepp, Carlos Farkas, Mario Galindo, Violeta Morín, María A. García‐Robles, Ariel F. Castro, Roxana Pincheira
    Molecular Oncology.2018; 12(7): 1026.     CrossRef
  • The combinational effect of E6/E7 siRNA and anti-miR-182 on apoptosis induction in HPV16-positive cervical cells
    Hamidreza Javadi, Abbas Sahebghadam Lotfi, Saman Hosseinkhani, Hossein Mehrani, Jafar Amani, Zahra Soheila Soheili, Zahra Hojati, Mehdi Kamali
    Artificial Cells, Nanomedicine, and Biotechnology.2018; 46(sup2): 727.     CrossRef
  • A Cu2+ complex induces the aggregation of human papillomavirus oncoprotein E6 and stabilizes p53
    Amit Kumar, Lars T. Kuhn, Jochen Balbach
    The FEBS Journal.2018; 285(16): 3013.     CrossRef
  • The Myb-related protein MYPOP is a novel intrinsic host restriction factor of oncogenic human papillomaviruses
    Elena Wüstenhagen, Fatima Boukhallouk, Inka Negwer, Krishnaraj Rajalingam, Frank Stubenrauch, Luise Florin
    Oncogene.2018; 37(48): 6275.     CrossRef
  • Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers
    Z. Ping Lin, Yong-Lian Zhu, Elena S. Ratner
    Frontiers in Oncology.2018;[Epub]     CrossRef
  • Development and validation of a multiplex reverse transcript real-time PCR for E6/E7 mRNA detection of high-risk human papillomavirus
    Caixia Pan, Jing Zhou, Jiangfeng Lyu, Xuyi Ren
    Journal of Medical Microbiology.2018; 67(10): 1509.     CrossRef
  • High-affinity binding with specific peptides endows EuW10a good luminescence probe for HPV E6 detection
    Yuxue Liu, Xinxin Yuan, Weixian Wang, Yuqing Wu, Lixin Wu
    New Journal of Chemistry.2018; 42(21): 17339.     CrossRef
  • Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response
    Diletta Francesca Squarzanti, Rita Sorrentino, Manuela Miriam Landini, Andrea Chiesa, Sabrina Pinato, Francesca Rocchio, Martina Mattii, Lorenza Penengo, Barbara Azzimonti
    Virology Journal.2018;[Epub]     CrossRef
  • Do Human Papilloma Viruses Play a Role in the Genesis of Cutaneous Malignancies?
    Mohamed JEMF Mabruk
    Journal of Dermatology & Cosmetology.2018;[Epub]     CrossRef
  • Nicotinic acetylcholine receptor gene polymorphism is not associated with tobacco-related oral squamous cell carcinoma
    Deepa Rajesh, SM Azeem Mohiyuddin, Sharath Balakrishna, AV Moideen Kutty
    Indian Journal of Cancer.2018; 55(4): 399.     CrossRef
  • Immune Checkpoint Inhibition in the Treatment of Gynecologic Cancer
    Kristen Anderson, Ramez N. Eskander
    Current Obstetrics and Gynecology Reports.2018; 7(1): 6.     CrossRef
  • Identification of fatal outcome in a childhood nasopharyngeal carcinoma patient by protein expression profiling
    Mohamed Saeed, Rolf Mertens, Rupert Handgretinger, Thomas Efferth
    International Journal of Oncology.2018;[Epub]     CrossRef
  • Integration of Oncogenes via Sleeping Beauty as a Mouse Model of HPV16+ Oral Tumors and Immunologic Control
    Yi-Hsin Lin, Ming-Chieh Yang, Ssu-Hsueh Tseng, Rosie Jiang, Andrew Yang, Emily Farmer, Shiwen Peng, Talia Henkle, Yung-Nien Chang, Chien-Fu Hung, T.-C. Wu
    Cancer Immunology Research.2018; 6(3): 305.     CrossRef
  • Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers
    Jialing Zhang, Tony Chen, Xinping Yang, Hui Cheng, Stephan S. Späth, Paul E. Clavijo, Jianhong Chen, Christopher Silvin, Natalia Issaeva, Xiulan Su, Wendell G. Yarbrough, Christina M. Annunziata, Zhong Chen, Carter Van Waes
    Cancer Research.2018; 78(16): 4613.     CrossRef
  • Relevant Allelic Frequency of Gene Polymorphism and Genetic Predisposition of Human Papillomavirus in Patients with Cervical Cancer
    Nikta Sajjadi, Reza Mirnejad, Malike Sharif, Vahhab Piranfar, Davood Zaeifi
    Modern Medical Laboratory Journal.2018; 1(2): 50.     CrossRef
  • Epidemiology and biology of cutaneous human papillomavirus
    Emily M Nunes, Valéria Talpe-Nunes, Laura Sichero
    Clinics.2018; 73: e489s.     CrossRef
  • Genome characterization of a bovine papillomavirus type 5 from cattle in the Amazon region, Brazil
    Flavio R. C. da Silva, Cíntia Daudt, Samuel P. Cibulski, Matheus N. Weber, Ana Paula M. Varela, Fabiana Q. Mayer, Paulo M. Roehe, Cláudio W. Canal
    Virus Genes.2017; 53(1): 130.     CrossRef
  • Exploring the potential of genome editing CRISPR-Cas9 technology
    Vijai Singh, Darren Braddick, Pawan Kumar Dhar
    Gene.2017; 599: 1.     CrossRef
  • Two-step chromatographic purification of glutathione S-transferase-tagged human papillomavirus type 16 E6 protein and its application for serology
    Mei Ling Xu, Seung Cheol Kim, Hyoung Jin Kim, Woong Ju, Yun Hwan Kim, Hong-Jin Kim
    Protein Expression and Purification.2017; 132: 19.     CrossRef
  • Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy
    Christian Bressy, Eric Hastie, Valery Z. Grdzelishvili
    Molecular Therapy - Oncolytics.2017; 5: 20.     CrossRef
  • MiR-23b controls ALDH1A1 expression in cervical cancer stem cells
    Weiwen Wang, Yang Li, Na Liu, Yu Gao, Long Li
    BMC Cancer.2017;[Epub]     CrossRef
  • Mad2 Overexpression Uncovers a Critical Role for TRIP13 in Mitotic Exit
    Daniel Henry Marks, Rozario Thomas, Yvette Chin, Riddhi Shah, Christine Khoo, Robert Benezra
    Cell Reports.2017; 19(9): 1832.     CrossRef
  • Genomic abnormalities in invasive endocervical adenocarcinoma correlate with pattern of invasion: biologic and clinical implications
    Anjelica Hodgson, Yutaka Amemiya, Arun Seth, Matthew Cesari, Bojana Djordjevic, Carlos Parra-Herran
    Modern Pathology.2017; 30(11): 1633.     CrossRef
  • Enhancing antitumor immunogenicity of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide to DNA encoding capsid protein L1 of Bovine papillomavirus
    Andrew Yang, Shiwen Peng, Emily Farmer, Qi Zeng, Max A. Cheng, Xiaowu Pang, T. -C. Wu, Chien-Fu Hung
    Cell & Bioscience.2017;[Epub]     CrossRef
  • Virus like particles as a platform for cancer vaccine development
    Hui Kian Ong, Wen Siang Tan, Kok Lian Ho
    PeerJ.2017; 5: e4053.     CrossRef
  • Expression of cell cycle-related proteins in oropharyngeal squamous cell carcinoma based on human papilloma virus status
    Koudai Tsuchida, Tamotsu Sugai, Noriyuki Uesugi, Kazuyuki Ishida, Kazuto Matsuura, Ikuro Sato, Kiyoto Shiga, Hiroaki Sato
    Oncology Reports.2017; 38(2): 908.     CrossRef
  • Correlation of hTERT Expression with Cervical Cytological Abnormalities and Human Papillomavirus Infection
    Vjosa A. Zejnullahu, Valon A. Zejnullahu, Slavica Josifovska, Nikola Vukovik, Kiril Pakovski, Sasho Panov
    PRILOZI.2017; 38(3): 143.     CrossRef
  • TAT‑mediated si‑hWAPL inhibits the invasion and metastasis of cervical cancer stem cells
    Pijun Gong, Chunyan Hu, Xi Zhou, Renxiao Wang, Zhao Duan
    Experimental and Therapeutic Medicine.2017;[Epub]     CrossRef
  • Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer (Review)
    Prakriti Sen, Pooja Ganguly, Niladri Ganguly
    Oncology Letters.2017;[Epub]     CrossRef
  • Decision management in transoral robotic surgery: Indications, individual patient selection, and role in the multidisciplinary treatment for head and neck cancer from a European perspective
    Balazs B. Lörincz, Nathan Jowett, Rainald Knecht
    Head & Neck.2016;[Epub]     CrossRef
  • The Role of p53 Gene in Cervical Carcinogenesis
    Garima, Sulekha Pandey, L. K. Pandey, A. K. Saxena, Nidhi Patel
    The Journal of Obstetrics and Gynecology of India.2016; 66(S1): 383.     CrossRef
  • Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer
    Samatha Bhat, Shama Prasada Kabekkodu, Ashish Noronha, Kapaettu Satyamoorthy
    Biochimie.2016; 121: 298.     CrossRef
  • Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma
    Ming Yann Lim, Kristina R. Dahlstrom, Erich M. Sturgis, Guojun Li
    Head & Neck.2016; 38(8): 1139.     CrossRef
  • A Giant Vulvar Mass: A Case Study of Cellular Angiofibroma
    Ümit Aydın, Hasan Terzi, Ünal Turkay, Ahmet Tuğrul Eruyar, Ahmet Kale
    Case Reports in Obstetrics and Gynecology.2016; 2016: 1.     CrossRef
  • Aptima HR-HPV testing from Diff-Quick-stained fine-needle aspiration smears of oropharyngeal squamous cell carcinoma
    Min Han, Cory T. Bernadt, Benjamin Murray, Steven M. Johnson, Jalal B. Jalaly, Telly Garcia, Laura J. Adhikari
    Journal of the American Society of Cytopathology.2016; 5(4): 221.     CrossRef
  • Loss of histone variant macroH2A2 expression associates with progression of anal neoplasm
    Wan-Hsiang Hu, Katsumi Miyai, Judith C Sporn, Linda Luo, Jean Y J Wang, Bard Cosman, Sonia Ramamoorthy
    Journal of Clinical Pathology.2016; 69(7): 627.     CrossRef
  • Targeting HPV‐infected cervical cancer cells with PEGylated liposomes encapsulating siRNA and the role of siRNA complexation with polyethylenimine
    Rachel M. Levine, Christina V. Dinh, Michael A. Harris, Efrosini Kokkoli
    Bioengineering & Translational Medicine.2016; 1(2): 168.     CrossRef
  • New Strategies for Multimodality Therapy in Treating Locally Advanced Cervix Cancer
    Jonathan Verma, Bradley J. Monk, Aaron H. Wolfson
    Seminars in Radiation Oncology.2016; 26(4): 344.     CrossRef
  • A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia
    Vânia Sammartino Mariano, Adriana Tarlá Lorenzi, Cristovam Scapulatempo-Neto, Maíra Degiovani Stein, Julio Cesar Possati Resende, Márcio Antoniazzi, Luisa Lina Villa, José Eduardo Levi, Adhemar Longatto-Filho, José Humberto Tavares Guerreiro Fregnani, Kal
    PLOS ONE.2016; 11(10): e0164892.     CrossRef
  • Inhibition of endoplasmic reticulum (ER) stress sensors sensitizes cancer stem-like cells to ER stress-mediated apoptosis
    Asaha Fujimoto, Kei Kawana, Ayumi Taguchi, Katsuyuki Adachi, Masakazu Sato, Hiroe Nakamura, Juri Ogishima, Mitsuyo Yoshida, Tomoko Inoue, Haruka Nishida, Kensuke Tomio, Aki Yamashita, Yoko Matsumoto, Takahide Arimoto, Osamu Wada-Hiraike, Katsutoshi Oda, T
    Oncotarget.2016; 7(32): 51854.     CrossRef
  • The potential of plants for the production and delivery of human papillomavirus vaccines
    Sergio Rosales-Mendoza, Dania O Govea-Alonso
    Expert Review of Vaccines.2015; 14(7): 1031.     CrossRef
  • NGS-based approach to determine the presence of HPV and their sites of integration in human cancer genome
    P Chandrani, V Kulkarni, P Iyer, P Upadhyay, R Chaubal, P Das, R Mulherkar, R Singh, A Dutt
    British Journal of Cancer.2015; 112(12): 1958.     CrossRef
  • An overview of new biomolecular pathways in pathogen-related cancers
    Maria Lina Tornesello, Luigi Buonaguro, Franco M Buonaguro
    Future Oncology.2015; 11(11): 1625.     CrossRef
  • Cellular angiofibroma in women: a review of the literature
    Vincenzo Dario Mandato, Susanna Santagni, Alberto Cavazza, Lorenzo Aguzzoli, Martino Abrate, Giovanni Battista La Sala
    Diagnostic Pathology.2015;[Epub]     CrossRef
  • Human papillomavirus and host genetic polymorphisms in carcinogenesis: A systematic review and meta-analysis
    Steven Habbous, Vincent Pang, Wei Xu, Eitan Amir, Geoffrey Liu
    Journal of Clinical Virology.2014; 61(2): 220.     CrossRef
  • Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer
    Matthew P Morrow, Jian Yan, Niranjan Y Sardesai
    Expert Review of Vaccines.2013; 12(3): 271.     CrossRef
  • ProExC is a novel marker for distinguishing between primary endometrial and endocervical adenocarcinomas
    Ghada E. Esheba
    Journal of the Egyptian National Cancer Institute.2013; 25(2): 87.     CrossRef
  • Canine distemper virus induces apoptosis in cervical tumor derived cell lines
    Helen L Del Puerto, Almir S Martins, Amy Milsted, Elaine M Souza-Fagundes, Gissandra F Braz, Barbara Hissa, Luciana O Andrade, Fabiana Alves, Daniela S Rajão, Rômulo C Leite, Anilton C Vasconcelos
    Virology Journal.2011;[Epub]     CrossRef
  • 23,471 View
  • 477 Download
  • 260 Crossref
Close layer
Original Article
Identification of Genes Involved in Liver Cancer Cell Growth Using an Antisense Library of Phage Genomic DNA
Yun Han Lee, Young Ho Kim, Jong Gu Park
Cancer Res Treat. 2004;36(4):246-254.   Published online August 31, 2004
DOI: https://doi.org/10.4143/crt.2004.36.4.246
AbstractAbstract PDFPubReaderePub
Purpose

Genes involved in liver cancer cell growth have been identified using an antisense library of large circular (LC-) genomic DNA of a recombinant M13 phage.

Materials and Methods

A subtracted cDNA library was constructed by combining procedures of suppression subtractive hybridization (SSH) and unidirectional cloning of the subtracted cDNA into an M13 phagemid vector. Utilizing the life cycle of M13 bacteriophages, LC-antisense molecules derived from 1,200 random cDNA clones selected by size were prepared from the culture supernatant of bacterial transformants. The antisense molecules were arrayed for transfection on 96-well plates preseeded with HepG2.

Results

When examined for growth inhibition after antisense transfection, 153 out of 1,200 LC-antisense molecules showed varying degrees of growth inhibitory effect to HepG2 cells. Sequence comparison of the 153 clones identified 58 unique genes. The observations were further extended by other cell-based assays.

Conclusion

These results suggest that the LC-antisense library offers potential for unique high-throughput screening to find genes involved in a specific biological function, and may prove to be an effective target validation system for gene-based drug discovery.

  • 8,082 View
  • 58 Download
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP